ğ‹‡ Â¦marchÂ¦ Â¦toÂ¦ ğ‹‡ Â¦augustÂ¦ Â¦2020Â¦
ğ‹‡ Â¦cons ul tÂ¦ Â¦theÂ¦ Â¦h igh l igh tsÂ¦ Â¦fromÂ¦ ğ‹‡ Â¦marchÂ¦ Â¦toÂ¦ ğ‹‡ Â¦augustÂ¦ Â¦2020Â¦
Â¦seriesÂ¦ Â¦ofÂ¦ Â¦testÂ¦ Â¦t ub esÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦dra w erÂ¦ 
Â¦31Â¦ ğ‹‡ Â¦augustÂ¦ Â¦2020Â¦ â–-â– ğ‹‡Â¦coronavirusÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦responseÂ¦ :â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦jo insÂ¦ Â¦theÂ¦  - Â¦19Â¦ ğ‹‡ Â¦vaccineÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦accessÂ¦ ğ‹‡ Â¦facilityÂ¦
ğ‹‡Â¦toÂ¦ Â¦acc el er ateÂ¦ Â¦theÂ¦ Â¦developmentÂ¦ Â¦andÂ¦ Â¦manufact ureÂ¦ Â¦ofÂ¦  - Â¦19Â¦ Â¦vaccinesÂ¦ Â¦forÂ¦ Â¦everyoneÂ¦ Â¦whoÂ¦ Â¦needsÂ¦ Â¦themÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦jo insÂ¦ Â¦theÂ¦ â– â€˜  - Â¦19Â¦ ğ‹‡ Â¦vaccineÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦accessÂ¦ ğ‹‡ Â¦facilityÂ¦ â€™ .
ğ‹‡Â¦co mm is sion erÂ¦ ğ‹‡ Â¦k y r ia k i desÂ¦ Â¦s ig ningÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦contr actÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦com pa nyÂ¦ ğ‹‡Â¦a st ra ğ‹‡ z en ec aÂ¦
Â¦27Â¦ ğ‹‡ Â¦augustÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦form allyÂ¦ Â¦signsÂ¦ Â¦firstÂ¦ Â¦contr actÂ¦ Â¦withÂ¦ ğ‹‡Â¦a st ra ğ‹‡ z en ec aÂ¦
ğ‹‡Â¦theÂ¦ Â¦firstÂ¦ Â¦contr actÂ¦ Â¦thatÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦neg o ti atedÂ¦ Â¦onÂ¦ Â¦be h al fÂ¦ Â¦ofÂ¦ Â¦theÂ¦  ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦ph ar m ac eut icalÂ¦ Â¦com pa nyÂ¦ Â¦ent eredÂ¦ Â¦intoÂ¦ Â¦forceÂ¦ Â¦followingÂ¦ Â¦theÂ¦ Â¦formalÂ¦ Â¦s ign at ureÂ¦ Â¦betweenÂ¦ ğ‹‡Â¦a st ra ğ‹‡ z en ec aÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ .
ğ‹‡ Â¦twoÂ¦ Â¦menÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦work s ho pÂ¦ 
Â¦25Â¦ ğ‹‡ Â¦augustÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦pro po sesÂ¦ Â¦toÂ¦ Â¦provideÂ¦ â–â‚¬ Â¦8 7Â¦ . Â¦3Â¦ Â¦billionÂ¦ Â¦inÂ¦ Â¦financialÂ¦ Â¦supportÂ¦ Â¦forÂ¦ Â¦16Â¦ ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦underÂ¦ 
ğ‹‡Â¦onÂ¦ Â¦24Â¦ Â¦andÂ¦ Â¦25Â¦ ğ‹‡ Â¦augustÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦presentedÂ¦ Â¦prop os alsÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğ‹‡ Â¦councilÂ¦ Â¦toÂ¦ Â¦gr antÂ¦ Â¦financialÂ¦ Â¦supportÂ¦ Â¦ofÂ¦ â–â‚¬ Â¦8 7Â¦ .
Â¦res ear c herÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦laboratoryÂ¦ 
Â¦20Â¦ ğ‹‡ Â¦augustÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦contin uesÂ¦ Â¦exp andingÂ¦ Â¦futureÂ¦ Â¦vaccinesÂ¦ Â¦port f o lioÂ¦ Â¦throughÂ¦ Â¦newÂ¦ Â¦t al ksÂ¦ Â¦withÂ¦ ğ‹‡ Â¦cu re ğ‹‡ vacÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦conclu dedÂ¦ Â¦expl or atoryÂ¦ Â¦t al ksÂ¦ Â¦withÂ¦ ğ‹‡ Â¦cu re ğ‹‡ vacÂ¦ Â¦toÂ¦ Â¦potentiallyÂ¦ Â¦pur ch aseÂ¦ Â¦aÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦ .
ğ‹‡Â¦aÂ¦ Â¦scient istÂ¦ Â¦atÂ¦ Â¦workÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦la bÂ¦ 
Â¦14Â¦ ğ‹‡ Â¦augustÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦rea chesÂ¦ Â¦firstÂ¦ Â¦a gr ee mentÂ¦ Â¦onÂ¦ Â¦aÂ¦ Â¦potentialÂ¦ Â¦vaccineÂ¦ Â¦withÂ¦ ğ‹‡Â¦a st ra ğ‹‡ z en ec aÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦reachedÂ¦ Â¦aÂ¦ Â¦firstÂ¦ Â¦a gr ee mentÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦ph ar m ac eut icalÂ¦ Â¦com pa nyÂ¦ ğ‹‡Â¦a st ra ğ‹‡ z en ec aÂ¦ Â¦toÂ¦ Â¦pur ch aseÂ¦ Â¦aÂ¦ Â¦potentialÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦ .
ğ‹‡ Â¦res ear c herÂ¦ Â¦workingÂ¦ Â¦onÂ¦ Â¦vaccineÂ¦ 
Â¦13Â¦ ğ‹‡ Â¦augustÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦conclu desÂ¦ Â¦furtherÂ¦ Â¦t al ksÂ¦ Â¦toÂ¦ Â¦sec ureÂ¦ Â¦futureÂ¦ Â¦vaccineÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦conclu dedÂ¦ Â¦expl or atoryÂ¦ Â¦t al ksÂ¦ Â¦withÂ¦ ğ‹‡ Â¦johnsonÂ¦ â–&â– ğ‹‡ Â¦johnsonÂ¦ Â¦toÂ¦ Â¦pur ch aseÂ¦ Â¦aÂ¦ Â¦potentialÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ .
ğ‹‡Â¦presidentÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦saidÂ¦ : â–â€œ ğ‹‡Â¦ourÂ¦ Â¦citizensÂ¦ 'â– Â¦livesÂ¦ Â¦andÂ¦ Â¦ourÂ¦ Â¦economyÂ¦ Â¦needÂ¦ Â¦aÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ .
ğ‹‡ Â¦researchÂ¦ Â¦la bÂ¦ 
Â¦11Â¦ ğ‹‡ Â¦augustÂ¦ Â¦2020Â¦ â–-â– Â¦23Â¦ Â¦newÂ¦ Â¦researchÂ¦ Â¦proj ectsÂ¦ Â¦toÂ¦ Â¦receiveÂ¦ â–â‚¬ Â¦12 8Â¦ Â¦millionÂ¦ Â¦inÂ¦  Â¦fundingÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦willÂ¦ Â¦supportÂ¦ Â¦23Â¦ Â¦newÂ¦ Â¦researchÂ¦ Â¦proj ectsÂ¦ Â¦withÂ¦ â–â‚¬ Â¦12 8Â¦ Â¦millionÂ¦ Â¦inÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦crisisÂ¦ .
ğ‹‡ Â¦sa no f iÂ¦ Â¦t al ksÂ¦ 
Â¦31Â¦ ğ‹‡ Â¦julyÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦conclu desÂ¦ Â¦t al ksÂ¦ Â¦toÂ¦ Â¦sec ureÂ¦ Â¦aÂ¦ Â¦futureÂ¦ Â¦coronavirusÂ¦ Â¦vaccineÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦conclu dedÂ¦ Â¦expl or atoryÂ¦ Â¦t al ksÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦ph ar m ac eut icalÂ¦ Â¦com pa nyÂ¦ ğ‹‡ Â¦sa no f iÂ¦ Â¦toÂ¦ Â¦pur ch aseÂ¦ Â¦aÂ¦ Â¦potentialÂ¦  - Â¦19Â¦ Â¦vaccineÂ¦ .
Â¦scient istÂ¦ 
Â¦29Â¦ ğ‹‡ Â¦julyÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦sec uresÂ¦  Â¦accessÂ¦ Â¦toÂ¦ ğ‹‡ Â¦remdesivirÂ¦ Â¦forÂ¦ Â¦treatmentÂ¦ Â¦ofÂ¦  - Â¦19Â¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦signedÂ¦ Â¦aÂ¦ â–â‚¬ Â¦6 3Â¦ Â¦millionÂ¦ Â¦contr actÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦ph ar m ac eut icalÂ¦ Â¦com pa nyÂ¦ ğ‹‡Â¦g il eadÂ¦ Â¦toÂ¦ Â¦sec ureÂ¦ Â¦treatmentÂ¦ Â¦dosesÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦ve k l uryÂ¦ ,â– Â¦theÂ¦ Â¦brandÂ¦ Â¦nameÂ¦ Â¦forÂ¦ ğ‹‡ Â¦remdesivirÂ¦ .
Â¦hand s ha keÂ¦ 
Â¦27Â¦ ğ‹‡ Â¦julyÂ¦ Â¦2020Â¦ â–-â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦la un chesÂ¦ Â¦callÂ¦ Â¦forÂ¦ Â¦in n ov ativeÂ¦ Â¦responseÂ¦ Â¦andÂ¦ Â¦recoveryÂ¦ Â¦part ne rs hipsÂ¦ Â¦betweenÂ¦  Â¦regionsÂ¦
ğ‹‡Â¦toÂ¦ Â¦supportÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦responseÂ¦ Â¦andÂ¦ Â¦recoveryÂ¦ ,â– Â¦andÂ¦ Â¦toÂ¦ Â¦helpÂ¦ Â¦regionsÂ¦ Â¦se izeÂ¦ Â¦opportun itiesÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦isÂ¦ Â¦la un chingÂ¦ Â¦aÂ¦ Â¦callÂ¦ Â¦forÂ¦ Â¦ex pr es sionsÂ¦ Â¦ofÂ¦ Â¦inter estÂ¦ Â¦forÂ¦ Â¦in n ov ationÂ¦ Â¦proj ectsÂ¦ Â¦betweenÂ¦ Â¦regionsÂ¦ ,â– Â¦f oc usingÂ¦ Â¦onÂ¦ Â¦fourÂ¦ Â¦the m aticÂ¦ Â¦areasÂ¦ :â– Â¦developmentÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦medicalÂ¦ Â¦val ueÂ¦ Â¦chainÂ¦ ;â– Â¦safetyÂ¦ Â¦andÂ¦ Â¦managementÂ¦ Â¦ofÂ¦ Â¦medicalÂ¦ Â¦w as teÂ¦ ;â– Â¦sus tain ableÂ¦ Â¦andÂ¦ Â¦digitalÂ¦ Â¦tour ismÂ¦ ;â– Â¦andÂ¦ Â¦theÂ¦ Â¦developmentÂ¦ Â¦ofÂ¦ Â¦hy dr og enÂ¦ Â¦techn ologiesÂ¦ Â¦inÂ¦ Â¦car b onÂ¦ - Â¦intensiveÂ¦ Â¦regionsÂ¦ .
ğ‹‡ Â¦u rs ulaÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ Â¦le y enÂ¦ 
Â¦23Â¦ ğ‹‡ Â¦julyÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦commissionÂ¦ ğ‹‡Â¦presidentÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦parliamentÂ¦ : â–â€œ ğ‹‡ Â¦togetherÂ¦ ,â– Â¦weÂ¦ Â¦nowÂ¦ Â¦haveÂ¦ Â¦theÂ¦ Â¦chanceÂ¦ Â¦toÂ¦ Â¦ach ieveÂ¦ Â¦somethingÂ¦ Â¦h ist or icÂ¦ Â¦forÂ¦ ğ‹‡ Â¦europeÂ¦ . â€
ğ‹‡Â¦followingÂ¦ Â¦anÂ¦ Â¦a gr ee mentÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦councilÂ¦ Â¦onÂ¦ ğ‹‡ Â¦europeÂ¦ â€™ Â¦sÂ¦ ğ‹‡ Â¦recoveryÂ¦ ğ‹‡ Â¦planÂ¦ ,â– ğ‹‡ Â¦commissionÂ¦ ğ‹‡Â¦presidentÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦saidÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦parliamentÂ¦ : â–â€œ ğ‹‡Â¦weÂ¦ Â¦nowÂ¦ Â¦haveÂ¦ Â¦ma ssiveÂ¦ Â¦andÂ¦ Â¦un pr ec ed entedÂ¦ Â¦financialÂ¦ Â¦fi re p ow erÂ¦ â–- â–â‚¬ Â¦1Â¦ .
Â¦b ud g etÂ¦ 
Â¦21Â¦ ğ‹‡ Â¦julyÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦europeanÂ¦ Â¦lea dersÂ¦ Â¦r eachÂ¦ Â¦aÂ¦ Â¦dealÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦recoveryÂ¦ Â¦planÂ¦ Â¦andÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦longÂ¦ - Â¦termÂ¦ Â¦b ud g etÂ¦ Â¦2021Â¦ - Â¦20 2 7Â¦
ğ‹‡Â¦afterÂ¦ Â¦4Â¦ Â¦longÂ¦ Â¦daysÂ¦ Â¦andÂ¦ Â¦n igh tsÂ¦ Â¦ofÂ¦ Â¦neg o ti ationsÂ¦ ,â–  Â¦lea dersÂ¦ Â¦successfullyÂ¦ Â¦agreedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦recoveryÂ¦ Â¦planÂ¦ Â¦forÂ¦ ğ‹‡ Â¦europeÂ¦ .
Â¦testingÂ¦ Â¦la bÂ¦ Â¦imageÂ¦ 
Â¦15Â¦ ğ‹‡ Â¦julyÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦commissionÂ¦ Â¦st re ng th ensÂ¦ Â¦preparednessÂ¦ Â¦forÂ¦ Â¦possibleÂ¦ Â¦futureÂ¦ Â¦coronavirusÂ¦ Â¦outbreaksÂ¦
ğ‹‡Â¦whileÂ¦ Â¦ai mingÂ¦ Â¦toÂ¦ Â¦sa veÂ¦ Â¦livesÂ¦ Â¦andÂ¦ Â¦toÂ¦ Â¦avoidÂ¦ Â¦lockdownsÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦isÂ¦ Â¦s et tingÂ¦ Â¦outÂ¦ Â¦immediateÂ¦ Â¦shortÂ¦ - Â¦termÂ¦ Â¦measuresÂ¦ Â¦toÂ¦ Â¦strengthenÂ¦  Â¦healthÂ¦ Â¦preparednessÂ¦ Â¦inÂ¦ Â¦caseÂ¦ Â¦ofÂ¦ Â¦possibleÂ¦ Â¦futureÂ¦ Â¦coronavirusÂ¦ Â¦outbreaksÂ¦ .
ğ‹‡ Â¦u rs ulaÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ ,â– ğ‹‡Â¦presidentÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦sp ee kingÂ¦ Â¦atÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦parliamentÂ¦ 
Â¦8Â¦ ğ‹‡ Â¦julyÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦presidentÂ¦ ğ‹‡ Â¦u rs ulaÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ :â– Â¦weÂ¦ Â¦canÂ¦ Â¦emer geÂ¦ Â¦stro ngerÂ¦ Â¦fromÂ¦ Â¦thisÂ¦ Â¦crisisÂ¦
ğ‹‡Â¦whenÂ¦ Â¦ad d re ssingÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦parliamentÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦occ as ionÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦startÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦g erm anÂ¦ ğ‹‡ Â¦pres ide ncyÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦councilÂ¦ Â¦ofÂ¦ Â¦theÂ¦  ,â– ğ‹‡Â¦presidentÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦saidÂ¦ : â–â€œ ğ‹‡ Â¦solidarityÂ¦ Â¦meansÂ¦ Â¦thatÂ¦ Â¦thoseÂ¦ Â¦whoÂ¦ Â¦needÂ¦ Â¦itÂ¦ ,â– Â¦getÂ¦ Â¦moreÂ¦ Â¦supportÂ¦ .
Â¦mo neyÂ¦ Â¦e ur osÂ¦ 
Â¦7Â¦ ğ‹‡ Â¦julyÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦summerÂ¦ Â¦2020Â¦ ğ‹‡ Â¦economicÂ¦ ğ‹‡ Â¦for ec astÂ¦ :â– ğ‹‡ Â¦u ne v enÂ¦ Â¦recoveryÂ¦ Â¦expectedÂ¦ Â¦toÂ¦ Â¦gainÂ¦ Â¦tra ctionÂ¦ Â¦inÂ¦ Â¦secondÂ¦ Â¦halfÂ¦ Â¦ofÂ¦ Â¦2020Â¦
ğ‹‡Â¦despiteÂ¦ Â¦theÂ¦ Â¦sw iftÂ¦ Â¦andÂ¦ Â¦comprehensiveÂ¦ Â¦policyÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦co ronaÂ¦ - Â¦crisisÂ¦ Â¦atÂ¦ Â¦bothÂ¦  Â¦andÂ¦ Â¦nationalÂ¦ Â¦levelsÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦summerÂ¦ Â¦2020Â¦ ğ‹‡ Â¦economicÂ¦ ğ‹‡ Â¦for ec astÂ¦ Â¦proj ectsÂ¦ Â¦aÂ¦ Â¦dee pÂ¦ Â¦re cess ionÂ¦ Â¦inÂ¦ Â¦theÂ¦  Â¦economyÂ¦ Â¦thisÂ¦ Â¦yearÂ¦ .
Â¦1Â¦ ğ‹‡ Â¦julyÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦youthÂ¦ ğ‹‡ Â¦employ mentÂ¦ ğ‹‡ Â¦supportÂ¦ :â– Â¦aÂ¦ Â¦ bridgeÂ¦ Â¦toÂ¦ Â¦jobsÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦nextÂ¦ Â¦gener ationÂ¦ Â¦ofÂ¦ ğ‹‡Â¦e ur op e ansÂ¦
ğ‹‡Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦ Â¦hasÂ¦ Â¦em ph as isedÂ¦ Â¦theÂ¦ Â¦oftenÂ¦ Â¦difficultÂ¦ Â¦startÂ¦ Â¦manyÂ¦ Â¦youngÂ¦ Â¦peopleÂ¦ Â¦faceÂ¦ ,â– Â¦butÂ¦ Â¦youngÂ¦ ğ‹‡Â¦e ur op e ansÂ¦ Â¦des er veÂ¦ Â¦theÂ¦ Â¦bestÂ¦ Â¦opportun itiesÂ¦ Â¦thatÂ¦ ğ‹‡ Â¦europeÂ¦ Â¦canÂ¦ Â¦offerÂ¦ .
ğ‹‡ Â¦globalÂ¦ Â¦responseÂ¦ Â¦eventÂ¦ 
Â¦27Â¦ ğ‹‡ Â¦juneÂ¦ Â¦2020Â¦ â–-â– ğ‹‡Â¦coronavirusÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦responseÂ¦ Â¦pl ed gingÂ¦ Â¦su mm itÂ¦ Â¦mo bi li sesÂ¦ Â¦anotherÂ¦ â–â‚¬ Â¦6Â¦ .
ğ‹‡Â¦theÂ¦ â– â€˜ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦go alÂ¦ :â– ğ‹‡ Â¦un iteÂ¦ Â¦forÂ¦ Â¦ourÂ¦ ğ‹‡ Â¦futureÂ¦ 'â– Â¦pl ed gingÂ¦ Â¦su mm itÂ¦ Â¦organ isedÂ¦ Â¦byÂ¦ ğ‹‡Â¦presidentÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦andÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡Â¦c it iz enÂ¦ Â¦onÂ¦ Â¦27Â¦ ğ‹‡ Â¦juneÂ¦ Â¦m ob il isedÂ¦ â–â‚¬ Â¦6Â¦ .
ğ‹‡ Â¦globalÂ¦ Â¦responseÂ¦ Â¦eventÂ¦ 
Â¦26Â¦ ğ‹‡ Â¦juneÂ¦ Â¦2020Â¦ â–-â– ğ‹‡Â¦coronavirusÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦responseÂ¦ :â– Â¦tu neÂ¦ Â¦inÂ¦ Â¦toÂ¦ Â¦su mm itÂ¦ Â¦andÂ¦ Â¦concer tÂ¦ Â¦onÂ¦ ğ‹‡ Â¦saturdayÂ¦ ,â– Â¦27Â¦ ğ‹‡ Â¦juneÂ¦ Â¦atÂ¦ Â¦3 pmÂ¦  .
ğ‹‡Â¦theÂ¦ Â¦globalÂ¦ Â¦pl ed gingÂ¦ Â¦su mm itÂ¦ Â¦andÂ¦ Â¦concer tÂ¦ Â¦organ isedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦andÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡Â¦c it iz enÂ¦ Â¦isÂ¦ Â¦happ eningÂ¦ Â¦thisÂ¦ ğ‹‡ Â¦saturdayÂ¦ â–( Â¦27Â¦ ğ‹‡ Â¦juneÂ¦ ).
ğ‹‡Â¦coronavirusÂ¦ Â¦globalÂ¦ Â¦responseÂ¦ 
Â¦22Â¦ ğ‹‡ Â¦juneÂ¦ Â¦2020Â¦ â–-â– ğ‹‡Â¦coronavirusÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦responseÂ¦ :â– ğ‹‡ Â¦commissionÂ¦ Â¦an no un cesÂ¦ Â¦worldÂ¦ Â¦lea dersÂ¦ â€™ â– Â¦su mm itÂ¦ Â¦andÂ¦ Â¦concer tÂ¦ Â¦lineÂ¦ - Â¦upÂ¦ Â¦forÂ¦ Â¦27Â¦ ğ‹‡ Â¦juneÂ¦ Â¦pl ed gingÂ¦ Â¦eventÂ¦
ğ‹‡ Â¦art istsÂ¦ Â¦haveÂ¦ Â¦theÂ¦ Â¦pow erÂ¦ Â¦toÂ¦ Â¦in sp ireÂ¦ Â¦changeÂ¦ .
Â¦17Â¦ ğ‹‡ Â¦juneÂ¦ Â¦2020Â¦ â–â€“â–   - Â¦19Â¦ Â¦vaccinesÂ¦ Â¦strategyÂ¦ Â¦un ve i ledÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦presentedÂ¦ Â¦aÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦strategyÂ¦ Â¦toÂ¦ Â¦acc el er ateÂ¦ Â¦theÂ¦ Â¦developmentÂ¦ ,â– Â¦manufact uringÂ¦ Â¦andÂ¦ Â¦dep lo y mentÂ¦ Â¦ofÂ¦ Â¦coronavirusÂ¦ Â¦vaccinesÂ¦ Â¦asÂ¦ Â¦itÂ¦ Â¦isÂ¦ Â¦ourÂ¦ Â¦bestÂ¦ Â¦b etÂ¦ Â¦atÂ¦ Â¦per ma ne ntlyÂ¦ Â¦be atingÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ Â¦withinÂ¦ Â¦aÂ¦ Â¦ti me f ra meÂ¦ Â¦ofÂ¦ Â¦12Â¦ Â¦toÂ¦ Â¦18Â¦ Â¦monthsÂ¦ ,â– Â¦ifÂ¦ Â¦notÂ¦ Â¦ear lierÂ¦ .
Â¦reopenÂ¦ Â¦euÂ¦ Â¦v is ualÂ¦ 
Â¦15Â¦ ğ‹‡ Â¦juneÂ¦ Â¦2020Â¦ â–-â– â€˜ ğ‹‡ Â¦reÂ¦ - Â¦openÂ¦  â€™ â–â€“â– Â¦aÂ¦ Â¦newÂ¦ Â¦webÂ¦ Â¦pl at formÂ¦ Â¦launchedÂ¦ Â¦toÂ¦ Â¦safelyÂ¦ Â¦resu meÂ¦ Â¦freeÂ¦ Â¦movementÂ¦ Â¦andÂ¦ Â¦tour ismÂ¦ Â¦inÂ¦ Â¦theÂ¦ 
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦launchedÂ¦ â– â€˜ ğ‹‡ Â¦reÂ¦ - Â¦openÂ¦  â€™ ,â– Â¦aÂ¦ Â¦webÂ¦ Â¦pl at formÂ¦ Â¦thatÂ¦ Â¦containsÂ¦ Â¦essentialÂ¦ Â¦informationÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦safeÂ¦ Â¦rela un chÂ¦ Â¦ofÂ¦ Â¦freeÂ¦ Â¦movementÂ¦ Â¦andÂ¦ Â¦tour ismÂ¦ Â¦acrossÂ¦ ğ‹‡ Â¦europeÂ¦ ,â– Â¦soÂ¦ Â¦thatÂ¦ Â¦youÂ¦ Â¦conf ide ntlyÂ¦ Â¦canÂ¦ Â¦en j o yÂ¦ Â¦yourÂ¦ Â¦up co mingÂ¦ Â¦holid aysÂ¦ .
Â¦manÂ¦ Â¦withÂ¦ Â¦maskÂ¦ Â¦chec kingÂ¦ Â¦hisÂ¦ Â¦phoneÂ¦ 
Â¦10Â¦ ğ‹‡ Â¦juneÂ¦ Â¦2020Â¦ â–â€“â–  Â¦stepsÂ¦ Â¦upÂ¦ Â¦actionÂ¦ Â¦toÂ¦ Â¦fightÂ¦ Â¦coronavirusÂ¦ Â¦dis infor mationÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğ‹‡ Â¦highÂ¦ ğ‹‡Â¦rep re se nt ativeÂ¦ Â¦areÂ¦ Â¦s te p pingÂ¦ Â¦upÂ¦ Â¦theÂ¦ Â¦fightÂ¦ Â¦againstÂ¦ Â¦coronavirusÂ¦ Â¦dis infor mationÂ¦ Â¦byÂ¦ Â¦prop os ingÂ¦ Â¦aÂ¦ Â¦wayÂ¦ Â¦for w ardÂ¦ Â¦inÂ¦ Â¦aÂ¦ ğ‹‡ Â¦jointÂ¦ ğ‹‡ Â¦commun icationÂ¦ .
ğ‹‡ Â¦int eri orÂ¦ Â¦ofÂ¦ Â¦anÂ¦ Â¦in n ov ationÂ¦ Â¦la bÂ¦ 
Â¦8Â¦ ğ‹‡ Â¦juneÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦toÂ¦ Â¦fightÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦andÂ¦ Â¦toÂ¦ Â¦supportÂ¦ Â¦theÂ¦ Â¦recoveryÂ¦ ,â–  Â¦gr antsÂ¦ â–â‚¬ Â¦3 1 4Â¦ Â¦millionÂ¦ Â¦toÂ¦ Â¦in n ov ativeÂ¦ Â¦companiesÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦announcedÂ¦ Â¦thatÂ¦ Â¦itÂ¦ Â¦hasÂ¦ Â¦a w ar dedÂ¦ Â¦3 6Â¦ Â¦companiesÂ¦ Â¦withÂ¦ Â¦nearlyÂ¦ â–â‚¬ Â¦1 66Â¦ Â¦millionÂ¦ ,â– Â¦viaÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦in n ov ationÂ¦ ğ‹‡ Â¦councilÂ¦ ğ‹‡ Â¦acc el er atorÂ¦ ğ‹‡ Â¦pil otÂ¦ ,â– Â¦willÂ¦ Â¦workÂ¦ Â¦onÂ¦ Â¦pi o ne eringÂ¦ Â¦proj ectsÂ¦ :â– Â¦bi oÂ¦ - Â¦dec on ta m inationÂ¦ Â¦w ip esÂ¦ ,â– Â¦developingÂ¦ Â¦lowÂ¦ - Â¦costÂ¦ Â¦massÂ¦ Â¦cas u alt yÂ¦ Â¦ventilationÂ¦ Â¦monitoringÂ¦ Â¦systemsÂ¦ ,â– Â¦andÂ¦ Â¦anÂ¦ Â¦antibodyÂ¦ Â¦pl at formÂ¦ Â¦toÂ¦ Â¦treatÂ¦ Â¦severeÂ¦ Â¦casesÂ¦ Â¦ofÂ¦ Â¦infectionÂ¦ 
Â¦4Â¦ ğ‹‡ Â¦juneÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦pl ed gesÂ¦ â–â‚¬ Â¦300Â¦ Â¦millionÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğ‹‡ Â¦vaccineÂ¦ ğ‹‡ Â¦al li anceÂ¦
ğ‹‡Â¦onÂ¦ Â¦4Â¦ ğ‹‡ Â¦juneÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦announcedÂ¦ Â¦aÂ¦ â–â‚¬ Â¦300Â¦ Â¦millionÂ¦ Â¦pl ed geÂ¦ Â¦toÂ¦ ğ‹‡ Â¦ga v iÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦vaccineÂ¦ ğ‹‡ Â¦al li anceÂ¦ ,â– Â¦forÂ¦ Â¦theÂ¦ Â¦periodÂ¦ Â¦2021Â¦ â€“ Â¦20 2 5Â¦ 
Â¦3Â¦ ğ‹‡ Â¦juneÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦commissionÂ¦ Â¦takesÂ¦ Â¦firstÂ¦ Â¦stepÂ¦ Â¦towardsÂ¦ Â¦adop tionÂ¦ Â¦ofÂ¦ Â¦aÂ¦ ğ‹‡ Â¦ph ar m ac eut icalÂ¦ ğ‹‡ Â¦strategyÂ¦ Â¦forÂ¦ ğ‹‡ Â¦europeÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦publishedÂ¦ Â¦aÂ¦ Â¦ro ad ma pÂ¦ Â¦onÂ¦ Â¦theÂ¦ ğ‹‡ Â¦ph ar m ac eut icalÂ¦ ğ‹‡ Â¦strategyÂ¦ Â¦forÂ¦ ğ‹‡ Â¦europeÂ¦ .
Â¦globalÂ¦ Â¦responseÂ¦ 
Â¦28Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–-â– ğ‹‡Â¦coronavirusÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦responseÂ¦ : â–â€œ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦go alÂ¦ :â– ğ‹‡ Â¦un iteÂ¦ ğ‹‡Â¦forÂ¦ ğ‹‡Â¦ourÂ¦ ğ‹‡ Â¦futureÂ¦ â€ â– Â¦k ickÂ¦ - Â¦offÂ¦ Â¦withÂ¦ Â¦supportÂ¦ Â¦fromÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡Â¦c it iz enÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦coronavirusÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦responseÂ¦ Â¦wasÂ¦ Â¦k ickÂ¦ - Â¦startedÂ¦ Â¦onÂ¦ Â¦4Â¦ ğ‹‡ Â¦mayÂ¦ Â¦andÂ¦ Â¦hasÂ¦ Â¦soÂ¦ Â¦farÂ¦ Â¦ra isedÂ¦ â–â‚¬ Â¦9Â¦ , Â¦8Â¦ Â¦billionÂ¦ Â¦forÂ¦ Â¦uni vers alÂ¦ Â¦accessÂ¦ Â¦toÂ¦ Â¦aff ord ableÂ¦ Â¦coronavirusÂ¦ Â¦vaccinationÂ¦ ,â– Â¦treatmentsÂ¦ Â¦andÂ¦ Â¦testingÂ¦ .
ğ‹‡ Â¦recoveryÂ¦ Â¦planÂ¦ Â¦forÂ¦ ğ‹‡ Â¦europeÂ¦ 
Â¦27Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦europeÂ¦ â€™ Â¦sÂ¦ Â¦mo mentÂ¦ :â– Â¦majorÂ¦ â–â‚¬ Â¦2Â¦ , Â¦4Â¦ Â¦tri ll ionÂ¦ ğ‹‡ Â¦recoveryÂ¦ ğ‹‡ Â¦planÂ¦ Â¦forÂ¦ ğ‹‡ Â¦europeÂ¦ Â¦un ve i ledÂ¦ Â¦toÂ¦ Â¦rep airÂ¦ Â¦andÂ¦ Â¦prepareÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦nextÂ¦ Â¦gener ationÂ¦
ğ‹‡Â¦toÂ¦ Â¦k ickÂ¦ - Â¦startÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦recoveryÂ¦ ,â– Â¦protectÂ¦ Â¦livesÂ¦ ,â– Â¦li ve li h oo dsÂ¦ Â¦andÂ¦ Â¦jobsÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦isÂ¦ Â¦prop os ingÂ¦ Â¦aÂ¦ Â¦majorÂ¦ â–â‚¬ Â¦2Â¦ , Â¦4Â¦ Â¦tri ll ionÂ¦ Â¦recoveryÂ¦ Â¦planÂ¦ Â¦whichÂ¦ Â¦isÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦usingÂ¦ Â¦theÂ¦ Â¦fullÂ¦ Â¦potentialÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦pow er fulÂ¦ ,â– Â¦mod er nÂ¦ Â¦andÂ¦ Â¦re va mp edÂ¦  Â¦b ud g etÂ¦ Â¦toÂ¦ Â¦deli verÂ¦ Â¦aÂ¦ Â¦moreÂ¦ Â¦sus tain ableÂ¦ ,â– Â¦digitalÂ¦ ,â– Â¦inc lus iveÂ¦ Â¦andÂ¦ Â¦f airÂ¦ ğ‹‡ Â¦europeÂ¦ 
Â¦26Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–-â– ğ‹‡Â¦coronavirusÂ¦ Â¦solidarityÂ¦ :â–  ğ‹‡ Â¦industryÂ¦ Â¦stepsÂ¦ Â¦inÂ¦ Â¦toÂ¦ Â¦protectÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦citizensÂ¦
ğ‹‡ Â¦europeanÂ¦ Â¦companiesÂ¦ Â¦haveÂ¦ Â¦shownÂ¦ Â¦ext ra ord in aryÂ¦ Â¦solidarityÂ¦ Â¦inÂ¦ Â¦thisÂ¦ Â¦crisisÂ¦ .
 Â¦se m esterÂ¦ 
Â¦20Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦se m esterÂ¦ ğ‹‡ Â¦springÂ¦ ğ‹‡ Â¦pack ageÂ¦ :â– ğ‹‡ Â¦recommendationsÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦coordin atedÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦
ğ‹‡Â¦onÂ¦ Â¦20Â¦ ğ‹‡ Â¦mayÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦proposedÂ¦ Â¦countryÂ¦ - Â¦specificÂ¦ Â¦recommendationsÂ¦ Â¦forÂ¦ Â¦allÂ¦  ğ‹‡ Â¦membersÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğ‹‡ Â¦unitedÂ¦ ğ‹‡ Â¦kingdomÂ¦ ,â– Â¦basedÂ¦ Â¦uponÂ¦ Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ â€™ Â¦sÂ¦ Â¦growthÂ¦ Â¦strategyÂ¦ ,â– Â¦whichÂ¦ Â¦pro mo tesÂ¦ Â¦comp e ti tiveÂ¦ Â¦sus tain a bilityÂ¦ Â¦toÂ¦ Â¦bu i ldÂ¦ Â¦anÂ¦ Â¦economyÂ¦ Â¦thatÂ¦ Â¦ worksÂ¦ Â¦forÂ¦ Â¦peopleÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦plan etÂ¦ .
Â¦res ear c herÂ¦ Â¦covidÂ¦ - Â¦19Â¦ 
Â¦19Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦coronavirusÂ¦ Â¦researchÂ¦ Â¦bo os tedÂ¦ Â¦byÂ¦ â–â‚¬ Â¦12 2Â¦ Â¦millionÂ¦ Â¦ofÂ¦ Â¦additionalÂ¦ Â¦fundingÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦m ob il isedÂ¦ Â¦anotherÂ¦ â–â‚¬ Â¦12 2Â¦ Â¦millionÂ¦ Â¦fromÂ¦ Â¦itsÂ¦ Â¦researchÂ¦ Â¦andÂ¦ Â¦in n ov ationÂ¦ Â¦programmeÂ¦ ,â– ğ‹‡Â¦h or iz onÂ¦ Â¦2020Â¦ ,â– Â¦forÂ¦ Â¦ur ge ntlyÂ¦ Â¦neededÂ¦ Â¦researchÂ¦ Â¦intoÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ .
Â¦airp ortÂ¦ 
Â¦13Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦safelyÂ¦ Â¦resu mingÂ¦ Â¦travelÂ¦ Â¦andÂ¦ Â¦re b oo tingÂ¦ ğ‹‡ Â¦europeÂ¦ â€™ Â¦sÂ¦ Â¦tour ismÂ¦ :â– ğ‹‡ Â¦commissionÂ¦ Â¦takesÂ¦ Â¦actionÂ¦
ğ‹‡Â¦toÂ¦ Â¦allowÂ¦ Â¦peopleÂ¦ Â¦toÂ¦ Â¦takeÂ¦ Â¦holid aysÂ¦ Â¦andÂ¦ Â¦catchÂ¦ Â¦upÂ¦ Â¦withÂ¦ Â¦theirÂ¦ Â¦friendsÂ¦ Â¦andÂ¦ Â¦familiesÂ¦ ,â– Â¦toÂ¦ Â¦letÂ¦ Â¦tour ismÂ¦ Â¦businessesÂ¦ Â¦reopenÂ¦ Â¦afterÂ¦ Â¦monthsÂ¦ Â¦ofÂ¦ Â¦beingÂ¦ Â¦loc kedÂ¦ Â¦downÂ¦ ,â– Â¦andÂ¦ Â¦toÂ¦ Â¦helpÂ¦ ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦helpÂ¦ Â¦graduallyÂ¦ Â¦l iftÂ¦ Â¦travelÂ¦ Â¦restrictionsÂ¦ Â¦whileÂ¦ Â¦ resp ectingÂ¦ Â¦theÂ¦ Â¦necessaryÂ¦ Â¦healthÂ¦ Â¦precau tionsÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦presentedÂ¦ Â¦aÂ¦ Â¦setÂ¦ Â¦ofÂ¦ Â¦guidelinesÂ¦ Â¦andÂ¦ Â¦recommendationsÂ¦ Â¦forÂ¦ Â¦tour istsÂ¦ ,â– Â¦travellersÂ¦ Â¦andÂ¦ Â¦businessesÂ¦ .
ğ‹‡Â¦medicalÂ¦ Â¦researchÂ¦ 
Â¦12Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ - â–â‚¬ Â¦11 7Â¦ Â¦millionÂ¦ Â¦gr an tedÂ¦ Â¦forÂ¦ ğ‹‡Â¦coronavirusÂ¦ Â¦treatmentsÂ¦ Â¦andÂ¦ Â¦diagno st icsÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦sel ectedÂ¦ Â¦8Â¦ Â¦largeÂ¦ - Â¦scaleÂ¦ Â¦researchÂ¦ Â¦proj ectsÂ¦ Â¦ai medÂ¦ Â¦atÂ¦ Â¦developingÂ¦ Â¦treatmentsÂ¦ Â¦andÂ¦ Â¦diagno st icsÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ ,â– Â¦inÂ¦ Â¦aÂ¦ Â¦fastÂ¦ - Â¦trackÂ¦ Â¦callÂ¦ Â¦forÂ¦ Â¦prop os alsÂ¦ Â¦launchedÂ¦ Â¦inÂ¦ ğ‹‡ Â¦marchÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡ Â¦in n ov ativeÂ¦ ğ‹‡ Â¦medicinesÂ¦ ğ‹‡ Â¦initi ativeÂ¦ â–(  ),â– Â¦aÂ¦ Â¦publicÂ¦ - Â¦privateÂ¦ Â¦part ne rs hipÂ¦ .
Â¦masksÂ¦ Â¦deliveryÂ¦ 
Â¦11Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦europeanÂ¦ Â¦solidarityÂ¦ Â¦inÂ¦ Â¦actionÂ¦ â–â€“â–  Â¦masksÂ¦ Â¦del iv eredÂ¦ Â¦toÂ¦ ğ‹‡ Â¦northÂ¦ ğ‹‡ Â¦mac ed o niaÂ¦ Â¦andÂ¦ ğ‹‡ Â¦mon te ne gr oÂ¦
ğ‹‡Â¦followingÂ¦ Â¦previousÂ¦ Â¦deli veriesÂ¦ Â¦toÂ¦ ğ‹‡ Â¦italyÂ¦ ,â– ğ‹‡ Â¦spainÂ¦ Â¦andÂ¦ ğ‹‡Â¦c ro at iaÂ¦ ,â– Â¦additionalÂ¦ Â¦bat chesÂ¦ Â¦ofÂ¦ Â¦masksÂ¦ Â¦areÂ¦ Â¦beingÂ¦ Â¦del iv eredÂ¦ Â¦toÂ¦ ğ‹‡ Â¦northÂ¦ ğ‹‡ Â¦mac ed o niaÂ¦ Â¦andÂ¦ ğ‹‡ Â¦mon te ne gr oÂ¦ Â¦viaÂ¦  â–â€“â– Â¦theÂ¦ Â¦commonÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦reser veÂ¦ Â¦ofÂ¦ Â¦medicalÂ¦ Â¦equipmentÂ¦ Â¦toÂ¦ Â¦helpÂ¦ Â¦countriesÂ¦ Â¦affectedÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦outbreakÂ¦ .
ğ‹‡ Â¦masksÂ¦ Â¦deliveryÂ¦ 
Â¦8Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦europeanÂ¦ Â¦solidarityÂ¦ Â¦inÂ¦ Â¦actionÂ¦ â–â€“â– Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦del iv ersÂ¦ Â¦firstÂ¦ Â¦bat chÂ¦ Â¦ofÂ¦ Â¦1Â¦ . Â¦5Â¦ Â¦millionÂ¦ Â¦masksÂ¦ Â¦toÂ¦ Â¦supportÂ¦  Â¦healthÂ¦ Â¦workersÂ¦
ğ‹‡Â¦aÂ¦ Â¦firstÂ¦ Â¦bat chÂ¦ Â¦ofÂ¦ Â¦1Â¦ , Â¦5Â¦ Â¦millionÂ¦ Â¦medicalÂ¦ Â¦masksÂ¦ Â¦isÂ¦ Â¦beingÂ¦ Â¦del iv eredÂ¦ Â¦toÂ¦ Â¦17Â¦ ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦andÂ¦ Â¦theÂ¦  Â¦toÂ¦ Â¦protectÂ¦ Â¦healthcareÂ¦ Â¦workersÂ¦ Â¦againstÂ¦ Â¦coronavirusÂ¦ .
Â¦h igh l ightÂ¦ 
Â¦7Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦commissionÂ¦ Â¦helpsÂ¦ ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦addressÂ¦ Â¦theÂ¦ Â¦shortagesÂ¦ Â¦ofÂ¦ Â¦healthÂ¦ Â¦workersÂ¦ Â¦sp e edÂ¦ Â¦upÂ¦ Â¦theÂ¦ Â¦recogn itionÂ¦ Â¦ofÂ¦ Â¦healthÂ¦ Â¦workersÂ¦ â€™ â– Â¦professionalÂ¦ Â¦qu al if icationsÂ¦
ğ‹‡Â¦toÂ¦ Â¦helpÂ¦ Â¦addressÂ¦ Â¦theÂ¦ Â¦shortagesÂ¦ Â¦ofÂ¦ Â¦healthÂ¦ Â¦workersÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦issuedÂ¦ Â¦aÂ¦ ğ‹‡ Â¦commun icationÂ¦ Â¦whichÂ¦ Â¦providesÂ¦ Â¦guidanceÂ¦ Â¦forÂ¦ ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ .
ğ‹‡Â¦ma pÂ¦ Â¦ofÂ¦ Â¦springÂ¦ Â¦economicÂ¦ Â¦for ec astÂ¦ 
Â¦6Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦springÂ¦ Â¦2020Â¦ ğ‹‡ Â¦economicÂ¦ ğ‹‡ Â¦for ec astÂ¦ â–â€“â– Â¦re cess ionÂ¦ Â¦andÂ¦ Â¦recoveryÂ¦
ğ‹‡Â¦despiteÂ¦ Â¦theÂ¦ Â¦sw iftÂ¦ Â¦andÂ¦ Â¦dec is iveÂ¦  Â¦andÂ¦ Â¦nationalÂ¦ Â¦responsesÂ¦ ,â– Â¦theÂ¦  Â¦economyÂ¦ Â¦willÂ¦ Â¦experienceÂ¦ Â¦aÂ¦ Â¦re cess ionÂ¦ Â¦thisÂ¦ Â¦yearÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦ Â¦cameÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦majorÂ¦ Â¦economicÂ¦ Â¦sh ockÂ¦ .
ğ‹‡ Â¦pi ct ureÂ¦ Â¦ofÂ¦ ğ‹‡Â¦presidentÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ 
Â¦4Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦coronavirusÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦responseÂ¦ : â–â‚¬ Â¦7Â¦ , Â¦4Â¦ Â¦billionÂ¦ Â¦ra isedÂ¦ Â¦fromÂ¦ Â¦don orsÂ¦ Â¦worldwideÂ¦ Â¦forÂ¦ Â¦uni vers alÂ¦ Â¦accessÂ¦ Â¦toÂ¦ Â¦vaccinesÂ¦ â–
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦reg ist eredÂ¦ â–â‚¬ Â¦7Â¦ .
ğ‹‡ Â¦pi ct ureÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦ban nerÂ¦ Â¦onÂ¦ Â¦theÂ¦ ğ‹‡Â¦b er la y mon tÂ¦ Â¦buildingÂ¦ 
Â¦2Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦finalÂ¦ Â¦coun t d ownÂ¦ :â– ğ‹‡Â¦coronavirusÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦responseÂ¦ Â¦pl ed gingÂ¦ Â¦ma ra th onÂ¦ Â¦st ar tsÂ¦ Â¦onÂ¦ ğ‹‡ Â¦mondayÂ¦ Â¦4Â¦ ğ‹‡ Â¦mayÂ¦
ğ‹‡Â¦withÂ¦ Â¦theÂ¦ ğ‹‡Â¦coronavirusÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦responseÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦unionÂ¦ Â¦isÂ¦ Â¦j oi ningÂ¦ Â¦for cesÂ¦ Â¦withÂ¦ Â¦globalÂ¦ Â¦part nersÂ¦ Â¦toÂ¦ Â¦k ickÂ¦ - Â¦startÂ¦ Â¦aÂ¦ Â¦worldwideÂ¦ Â¦pl ed gingÂ¦ Â¦effortÂ¦ Â¦toÂ¦ Â¦developÂ¦ Â¦treatmentsÂ¦ ,â– Â¦vaccinesÂ¦ Â¦andÂ¦ Â¦diagno st icsÂ¦ .
ğ‹‡Â¦presidentÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦saidÂ¦ : â–â€œ ğ‹‡Â¦onÂ¦ Â¦4Â¦ ğ‹‡ Â¦mayÂ¦ ,â– Â¦weÂ¦ Â¦wantÂ¦ Â¦toÂ¦ Â¦bringÂ¦ Â¦theÂ¦ Â¦worldÂ¦ Â¦togetherÂ¦ Â¦toÂ¦ Â¦deli verÂ¦ Â¦onÂ¦ Â¦preventionÂ¦ ,â– Â¦diagno st icsÂ¦ Â¦andÂ¦ Â¦treatmentsÂ¦ Â¦againstÂ¦ Â¦coronavirusÂ¦ .
Â¦onlineÂ¦ Â¦cons um ersÂ¦ 
Â¦30Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦do ub lesÂ¦ Â¦downÂ¦ Â¦onÂ¦ Â¦pre v eningÂ¦ Â¦s ca msÂ¦ Â¦andÂ¦ Â¦protectingÂ¦ Â¦cons um ersÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦isÂ¦ Â¦com mit tedÂ¦ Â¦toÂ¦ Â¦protectingÂ¦ Â¦cons um ersÂ¦ Â¦onlineÂ¦ â–â€“â– Â¦especiallyÂ¦ Â¦duringÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦ Â¦whereÂ¦ Â¦someÂ¦ Â¦ro gueÂ¦ Â¦act orsÂ¦ Â¦areÂ¦ Â¦pro mo tingÂ¦ Â¦falseÂ¦ Â¦cl ai msÂ¦ Â¦orÂ¦ Â¦sc amÂ¦ Â¦productsÂ¦ .
Â¦w ester nÂ¦ Â¦b al k ansÂ¦ Â¦aidÂ¦ 
Â¦29Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦t ac k lingÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦crisisÂ¦ :â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦stepsÂ¦ Â¦upÂ¦ Â¦itsÂ¦ Â¦supportÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğ‹‡Â¦w ester nÂ¦ ğ‹‡Â¦b al k ansÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦announcedÂ¦ Â¦overÂ¦ â–â‚¬ Â¦3Â¦ .
ğ‹‡ Â¦val di sÂ¦ ğ‹‡Â¦d om br ov s k i sÂ¦ ğ‹‡Â¦ pressÂ¦ ğ‹‡ Â¦confer enceÂ¦ 
Â¦28Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦ban kingÂ¦ Â¦pack ageÂ¦ :â– Â¦suppor tingÂ¦ Â¦householdsÂ¦ Â¦andÂ¦ Â¦businessesÂ¦ Â¦inÂ¦ Â¦theÂ¦ 
ğ‹‡Â¦toÂ¦ Â¦ensureÂ¦ Â¦thatÂ¦ Â¦ban ksÂ¦ Â¦canÂ¦ Â¦continueÂ¦ Â¦toÂ¦ Â¦l endÂ¦ Â¦mo neyÂ¦ ,â– Â¦supportÂ¦ Â¦theÂ¦ Â¦economyÂ¦ Â¦andÂ¦ Â¦helpÂ¦ Â¦mitigateÂ¦ Â¦theÂ¦ Â¦economicÂ¦ Â¦imp ac tsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦coronavirusÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦adop tedÂ¦ Â¦aÂ¦ Â¦ban kingÂ¦ Â¦pack ageÂ¦ .
Â¦globalÂ¦ Â¦su mm itÂ¦ 
Â¦27Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–-â–  Â¦la un chesÂ¦ Â¦globalÂ¦ Â¦pl ed gingÂ¦ Â¦effortÂ¦ Â¦withÂ¦ Â¦part nersÂ¦
ğ‹‡Â¦toÂ¦ Â¦developÂ¦ Â¦andÂ¦ Â¦dep lo yÂ¦ Â¦safeÂ¦ ,â– Â¦effectiveÂ¦ Â¦andÂ¦ Â¦aff ord ableÂ¦ Â¦diagno st icsÂ¦ ,â– Â¦therap eut icsÂ¦ Â¦andÂ¦ Â¦vaccinesÂ¦ Â¦againstÂ¦ Â¦coronavirusÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦unionÂ¦ Â¦isÂ¦ Â¦j oi ningÂ¦ Â¦for cesÂ¦ Â¦withÂ¦ Â¦globalÂ¦ Â¦part nersÂ¦ Â¦toÂ¦ Â¦k ickÂ¦ - Â¦startÂ¦ Â¦aÂ¦ Â¦pl ed gingÂ¦ Â¦effortÂ¦ â–â€“â– Â¦theÂ¦ ğ‹‡Â¦coronavirusÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦responseÂ¦ â–â€“â– Â¦startingÂ¦ Â¦onÂ¦ Â¦4Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ .
Â¦u rs ulaÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ Â¦le y enÂ¦ Â¦videoÂ¦ Â¦confer enceÂ¦ 
Â¦24Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦toÂ¦ Â¦sh ap eÂ¦ Â¦aÂ¦ Â¦commonÂ¦ Â¦recoveryÂ¦ Â¦planÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦re va mp edÂ¦  Â¦longÂ¦ - Â¦termÂ¦ Â¦b ud g etÂ¦ Â¦atÂ¦ Â¦itsÂ¦ Â¦heartÂ¦ â–
ğ‹‡ Â¦europeanÂ¦ Â¦lea dersÂ¦ Â¦t as kedÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦withÂ¦ Â¦sha pingÂ¦ Â¦aÂ¦ Â¦co ll ectiveÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦crisisÂ¦ Â¦followingÂ¦ Â¦aÂ¦ Â¦v ide oc on fer enceÂ¦ Â¦onÂ¦ Â¦23Â¦ ğ‹‡ Â¦aprilÂ¦ .
Â¦a gr ic ol t ureÂ¦ Â¦programmesÂ¦ 
Â¦23Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦ex cep tionalÂ¦ Â¦measuresÂ¦ Â¦toÂ¦ Â¦supportÂ¦ Â¦theÂ¦ Â¦a gr ic ult uralÂ¦ Â¦foodÂ¦ Â¦sectorÂ¦
ğ‹‡Â¦toÂ¦ Â¦sw if t lyÂ¦ Â¦supportÂ¦ Â¦a gr ic ult uralÂ¦ Â¦sectorÂ¦ Â¦andÂ¦ Â¦foodÂ¦ Â¦marketsÂ¦ Â¦followingÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦proposedÂ¦ Â¦ex cep tionalÂ¦ Â¦measuresÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦pro po sesÂ¦ Â¦toÂ¦ Â¦gr antÂ¦ Â¦privateÂ¦ Â¦stor ageÂ¦ Â¦aidÂ¦ Â¦forÂ¦ Â¦d ai ryÂ¦ Â¦andÂ¦ Â¦meatÂ¦ Â¦productsÂ¦ ,â– Â¦f lexibilityÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦implement ationÂ¦ Â¦ofÂ¦ Â¦marketÂ¦ Â¦supportÂ¦ Â¦programmesÂ¦ Â¦toÂ¦ Â¦ref oc usÂ¦ Â¦fundingÂ¦ Â¦priorit iesÂ¦ ,â– Â¦andÂ¦ Â¦ex cep tionalÂ¦ Â¦d er og ationÂ¦ Â¦fromÂ¦  Â¦comp et itionÂ¦ Â¦ru lesÂ¦ Â¦toÂ¦ Â¦st ab il iseÂ¦ Â¦theÂ¦ Â¦marketsÂ¦ Â¦inÂ¦ Â¦differentÂ¦ Â¦sectorsÂ¦ .
 Â¦f la gsÂ¦ 
Â¦22Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–- â–â‚¬ Â¦3Â¦ Â¦billionÂ¦ Â¦financialÂ¦ Â¦assistanceÂ¦ Â¦pack ageÂ¦ Â¦forÂ¦ Â¦tenÂ¦ Â¦ne igh bo uringÂ¦ Â¦countriesÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦proposedÂ¦ Â¦aÂ¦ â–â‚¬ Â¦3Â¦ Â¦billionÂ¦ Â¦mac r oÂ¦ - Â¦financialÂ¦ Â¦assistanceÂ¦ Â¦pack ageÂ¦ Â¦toÂ¦ Â¦tenÂ¦ Â¦en l ar ge mentÂ¦ Â¦andÂ¦ Â¦ne igh b our h oodÂ¦ Â¦part nersÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦ai mÂ¦ Â¦toÂ¦ Â¦limitÂ¦ Â¦theÂ¦ Â¦economicÂ¦ Â¦f al lo utÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦crisisÂ¦ Â¦inÂ¦ Â¦partnerÂ¦ Â¦countriesÂ¦ .
ğ‹‡ Â¦imageÂ¦ Â¦ofÂ¦ Â¦handsÂ¦ Â¦wearingÂ¦ Â¦glovesÂ¦ 
Â¦21Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–-â–  Â¦mo bi li sesÂ¦ Â¦supportÂ¦ Â¦forÂ¦ ğ‹‡ Â¦italyÂ¦ ,â– ğ‹‡Â¦c ro at iaÂ¦ Â¦andÂ¦ Â¦ne igh bo uringÂ¦ Â¦countriesÂ¦
ğ‹‡Â¦theÂ¦  Â¦coordin atesÂ¦ Â¦andÂ¦ Â¦c oÂ¦ - Â¦f in ancesÂ¦ Â¦theÂ¦ Â¦deliveryÂ¦ Â¦ofÂ¦ Â¦aidÂ¦ Â¦sh ip mentsÂ¦ Â¦inÂ¦ Â¦theÂ¦  Â¦andÂ¦ Â¦inÂ¦ Â¦ne igh bo uringÂ¦ Â¦countriesÂ¦ ,â– Â¦afterÂ¦ Â¦re que stsÂ¦ Â¦forÂ¦ Â¦assistanceÂ¦ Â¦viaÂ¦ Â¦theÂ¦  ğ‹‡Â¦c iv ilÂ¦ ğ‹‡ Â¦protectionÂ¦ ğ‹‡ Â¦mechan ismÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦fightÂ¦ Â¦againstÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦ .
ğ‹‡ Â¦imageÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦ser verÂ¦ Â¦roomÂ¦ 
Â¦20Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦coronavirusÂ¦ :â– ğ‹‡ Â¦newÂ¦ Â¦dataÂ¦ Â¦sharingÂ¦ Â¦pl at formÂ¦ Â¦forÂ¦ Â¦researchersÂ¦
ğ‹‡Â¦anÂ¦   - Â¦19Â¦ ğ‹‡Â¦dataÂ¦ ğ‹‡ Â¦pl at formÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦establishedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦andÂ¦ Â¦part nersÂ¦ Â¦toÂ¦ Â¦rapidlyÂ¦ Â¦collectÂ¦ Â¦andÂ¦ Â¦shareÂ¦ Â¦comprehensiveÂ¦ Â¦coronavirusÂ¦ Â¦researchÂ¦ Â¦dataÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦  Â¦se qu encesÂ¦ ,â– Â¦proteinÂ¦ Â¦st ru ct uresÂ¦ ,â– Â¦dataÂ¦ Â¦fromÂ¦ Â¦preÂ¦ - Â¦clinicalÂ¦ Â¦researchÂ¦ Â¦andÂ¦ Â¦clinicalÂ¦ Â¦trialsÂ¦ ,â– Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦epidemiologicalÂ¦ Â¦dataÂ¦ ,â– Â¦toÂ¦ Â¦advanceÂ¦ Â¦researchÂ¦ Â¦effortsÂ¦ .
Â¦pas se ngerÂ¦ Â¦inÂ¦ Â¦anÂ¦ Â¦airp ortÂ¦ 
Â¦17Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–-â– ğ‹‡Â¦overÂ¦ Â¦500Â¦ , Â¦000Â¦  Â¦citizensÂ¦ Â¦br oughtÂ¦ Â¦homeÂ¦
ğ‹‡Â¦theÂ¦  Â¦hasÂ¦ Â¦manag edÂ¦ Â¦toÂ¦ Â¦bringÂ¦ Â¦homeÂ¦ Â¦overÂ¦ Â¦halfÂ¦ Â¦aÂ¦ Â¦millionÂ¦ Â¦citizensÂ¦ Â¦affectedÂ¦ Â¦byÂ¦ Â¦coronavirusÂ¦ Â¦travelÂ¦ Â¦restrictionsÂ¦ Â¦byÂ¦ Â¦fundingÂ¦ Â¦rep at ri ationÂ¦ Â¦flightsÂ¦ Â¦andÂ¦ Â¦carryingÂ¦ Â¦outÂ¦ Â¦int en seÂ¦ Â¦cons ularÂ¦ Â¦co op er ationÂ¦ .
Â¦u rs ulaÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ Â¦le y enÂ¦ Â¦ pressÂ¦ Â¦confer enceÂ¦ 
Â¦16Â¦ ğ‹‡ Â¦aprilÂ¦ â–â€“â– Â¦2020Â¦ â–â€“â– ğ‹‡Â¦presidentÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ : â–â€œ ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦b ud g etÂ¦ Â¦willÂ¦ Â¦beÂ¦ Â¦theÂ¦ Â¦m ot he rs hipÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦europeÂ¦ â€™ Â¦sÂ¦ Â¦recoveryÂ¦ â€
ğ‹‡Â¦despiteÂ¦ ğ‹‡ Â¦europeÂ¦ â€™ Â¦sÂ¦ Â¦co ll ectiveÂ¦ Â¦responseÂ¦ Â¦beingÂ¦ Â¦wellÂ¦ Â¦aboveÂ¦ â–â‚¬ Â¦3Â¦ Â¦tri ll ionÂ¦ â–â€“â– Â¦theÂ¦ Â¦mostÂ¦ Â¦imp re ssiveÂ¦ Â¦responseÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦worldÂ¦ â–-â– Â¦moreÂ¦ Â¦isÂ¦ Â¦neededÂ¦ ,â– ğ‹‡Â¦presidentÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦saidÂ¦ Â¦atÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦parliamentÂ¦ .
Â¦w omanÂ¦ Â¦h ol dingÂ¦ Â¦herÂ¦ Â¦phoneÂ¦ 
Â¦16Â¦ ğ‹‡ Â¦aprilÂ¦ â–â€“â– Â¦2020Â¦ â–â€“â– ğ‹‡Â¦aÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦approachÂ¦ Â¦toÂ¦ Â¦tracingÂ¦ Â¦appsÂ¦ â–â€“â– Â¦completelyÂ¦ Â¦volu nt aryÂ¦ Â¦andÂ¦ Â¦fullyÂ¦ Â¦ resp ectingÂ¦ Â¦privacyÂ¦
ğ‹‡Â¦toÂ¦ Â¦establishÂ¦ Â¦volu nt aryÂ¦ Â¦contactÂ¦ Â¦tracingÂ¦ Â¦andÂ¦ Â¦war ningÂ¦ Â¦systemsÂ¦ Â¦thatÂ¦ Â¦fullyÂ¦ Â¦ resp ectÂ¦ Â¦privacyÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦putÂ¦ Â¦for w ardÂ¦ Â¦aÂ¦ Â¦to ol bo xÂ¦ Â¦andÂ¦ Â¦guidelinesÂ¦ .
Â¦char lesÂ¦ Â¦mi ch elÂ¦ Â¦andÂ¦ Â¦u rs ulaÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ Â¦le y enÂ¦ 
Â¦15Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦aÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦ro ad ma pÂ¦ Â¦toÂ¦ Â¦l if tingÂ¦ Â¦containmentÂ¦ Â¦measuresÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ ,â– Â¦inÂ¦ Â¦co op er ationÂ¦ Â¦withÂ¦ Â¦theÂ¦ ğ‹‡Â¦presidentÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦councilÂ¦ Â¦putÂ¦ Â¦for w ardÂ¦ Â¦aÂ¦ Â¦ro ad ma pÂ¦ ,â– Â¦recommendationsÂ¦ Â¦andÂ¦ Â¦keyÂ¦ Â¦princ ip lesÂ¦ Â¦toÂ¦ Â¦l if tingÂ¦ Â¦theÂ¦ Â¦containmentÂ¦ Â¦measuresÂ¦ .
ğ‹‡ Â¦protectiveÂ¦ Â¦medicalÂ¦ Â¦equipmentÂ¦ 
Â¦14Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–â€“â– â‚¬ Â¦2Â¦ , Â¦7Â¦ Â¦billionÂ¦ Â¦fromÂ¦ Â¦theÂ¦  Â¦b ud g etÂ¦ Â¦toÂ¦ Â¦supportÂ¦ Â¦theÂ¦ Â¦healthcareÂ¦ Â¦sectorÂ¦
ğ‹‡Â¦toÂ¦ Â¦directlyÂ¦ Â¦supportÂ¦ Â¦healthcareÂ¦ Â¦systemsÂ¦ Â¦inÂ¦  Â¦countriesÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦proposedÂ¦ Â¦toÂ¦ Â¦activ ateÂ¦ Â¦theÂ¦  â€™ Â¦sÂ¦ ğ‹‡ Â¦emergencyÂ¦ ğ‹‡ Â¦supportÂ¦ ğ‹‡ Â¦inst ru mentÂ¦ â–â€“â– Â¦aÂ¦ Â¦measureÂ¦ Â¦thatÂ¦ Â¦thatÂ¦ ğ‹‡ Â¦councilÂ¦ Â¦quicklyÂ¦ Â¦approvedÂ¦ Â¦onÂ¦ Â¦14Â¦ ğ‹‡ Â¦aprilÂ¦ .
Â¦pi llsÂ¦ 
Â¦8Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–â€“â– â‚¬ Â¦15Â¦ . Â¦6Â¦ Â¦billionÂ¦ Â¦forÂ¦ Â¦globalÂ¦  Â¦coronavirusÂ¦ Â¦responseÂ¦ ;â–  Â¦callsÂ¦ Â¦onÂ¦ ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦toÂ¦ Â¦ensureÂ¦ Â¦av ai labilityÂ¦ Â¦ofÂ¦ Â¦medicinesÂ¦
ğ‹‡Â¦toÂ¦ Â¦fightÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦acrossÂ¦ Â¦theÂ¦ Â¦gl ob eÂ¦ ,â– Â¦theÂ¦  Â¦willÂ¦ Â¦supportÂ¦ Â¦theÂ¦ Â¦publicÂ¦ Â¦healthÂ¦ Â¦andÂ¦ Â¦addressÂ¦ Â¦theÂ¦ Â¦hu ma ni ta ri anÂ¦ Â¦andÂ¦ Â¦s an it aryÂ¦ Â¦needsÂ¦ Â¦ofÂ¦ Â¦partnerÂ¦ Â¦countriesÂ¦ Â¦acrossÂ¦ Â¦theÂ¦ Â¦gl ob eÂ¦ Â¦byÂ¦ Â¦providingÂ¦ Â¦financialÂ¦ Â¦assistanceÂ¦ Â¦ofÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ â–â‚¬ Â¦15Â¦ .
Â¦coronavirusÂ¦ Â¦medicalÂ¦ Â¦unitÂ¦ 
Â¦ 07Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–-â–  ğ‹‡Â¦medicalÂ¦ ğ‹‡ Â¦cor psÂ¦ Â¦dep lo y edÂ¦ Â¦toÂ¦ ğ‹‡ Â¦italyÂ¦
ğ‹‡ Â¦todayÂ¦ ,â– Â¦theÂ¦  ğ‹‡Â¦medicalÂ¦ ğ‹‡ Â¦cor psÂ¦ Â¦coordin atedÂ¦ Â¦byÂ¦ Â¦theÂ¦  ğ‹‡ Â¦emergencyÂ¦ ğ‹‡ Â¦responseÂ¦ ğ‹‡Â¦co ord inationÂ¦ ğ‹‡ Â¦centreÂ¦ Â¦disp at chedÂ¦ Â¦aÂ¦ Â¦teamÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦doctorsÂ¦ Â¦andÂ¦ Â¦nur sesÂ¦ Â¦fromÂ¦ ğ‹‡ Â¦ro ma niaÂ¦ Â¦andÂ¦ ğ‹‡ Â¦nor wayÂ¦ Â¦toÂ¦ ğ‹‡Â¦b er g a m oÂ¦ .
ğ‹‡ Â¦financialÂ¦ Â¦aidÂ¦ Â¦coronavirusÂ¦ 
Â¦0 6Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–â€“â– â‚¬ Â¦8Â¦ Â¦billionÂ¦ Â¦toÂ¦ Â¦supportÂ¦ Â¦someÂ¦ Â¦100Â¦ , Â¦000Â¦ ğ‹‡ Â¦europeanÂ¦ Â¦businessesÂ¦
ğ‹‡ Â¦fundingÂ¦ Â¦toÂ¦ Â¦supportÂ¦ Â¦andÂ¦ Â¦provideÂ¦ Â¦reliefÂ¦ Â¦toÂ¦ Â¦someÂ¦ Â¦100Â¦ , Â¦000Â¦ Â¦businessesÂ¦ Â¦hitÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦economicÂ¦ Â¦conse qu encesÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦coronavirusÂ¦ Â¦willÂ¦ Â¦beÂ¦ Â¦availableÂ¦ Â¦inÂ¦ ğ‹‡ Â¦aprilÂ¦ Â¦asÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦in ve st mentÂ¦ ğ‹‡Â¦f undÂ¦ Â¦un l ockÂ¦ â–â‚¬ Â¦8Â¦ Â¦billionÂ¦ Â¦fromÂ¦ Â¦t han ksÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦f undÂ¦ Â¦forÂ¦ ğ‹‡ Â¦str at eg icÂ¦ ğ‹‡ Â¦in ve st mentsÂ¦ .
Â¦workersÂ¦ Â¦produc ingÂ¦ Â¦masksÂ¦ 
Â¦0 3Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦post po ningÂ¦ Â¦reg ulationÂ¦ Â¦forÂ¦ Â¦medicalÂ¦ Â¦devicesÂ¦ ,â– Â¦l if tingÂ¦ Â¦c us to msÂ¦ Â¦d ut iesÂ¦ Â¦forÂ¦ Â¦protectiveÂ¦ Â¦equipmentÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦proposedÂ¦ Â¦toÂ¦ Â¦post p oneÂ¦ Â¦regulationsÂ¦ Â¦onÂ¦ Â¦medicalÂ¦ Â¦devicesÂ¦ Â¦byÂ¦ Â¦oneÂ¦ Â¦yearÂ¦ Â¦toÂ¦ Â¦allowÂ¦ Â¦manufactur ersÂ¦ Â¦toÂ¦ Â¦focusÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦productionÂ¦ Â¦ofÂ¦ Â¦criticalÂ¦ Â¦medicalÂ¦ Â¦devicesÂ¦ Â¦andÂ¦ Â¦avoidingÂ¦ Â¦shortagesÂ¦ Â¦orÂ¦ Â¦delaysÂ¦ Â¦potentiallyÂ¦ Â¦causedÂ¦ Â¦byÂ¦ Â¦reg ulatoryÂ¦ Â¦bo d iesÂ¦ ,â– Â¦the re byÂ¦ Â¦andÂ¦ Â¦sa vingÂ¦ Â¦livesÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦alsoÂ¦ Â¦deci dedÂ¦ Â¦toÂ¦ Â¦temporarilyÂ¦ Â¦l iftÂ¦ Â¦c us to msÂ¦ Â¦d ut iesÂ¦ Â¦andÂ¦  Â¦onÂ¦ Â¦theÂ¦ Â¦imp ortÂ¦ Â¦ofÂ¦ Â¦medicalÂ¦ Â¦devicesÂ¦ Â¦andÂ¦ Â¦protectiveÂ¦ Â¦equipmentÂ¦ Â¦fromÂ¦ Â¦thirdÂ¦ Â¦countriesÂ¦ .
ğ‹‡ Â¦u rs ulaÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ ğ‹‡Â¦presidentÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ 
Â¦0 2Â¦ ğ‹‡ Â¦aprilÂ¦ â–-â– ğ‹‡Â¦coronavirusÂ¦ Â¦responseÂ¦ :â– ğ‹‡ Â¦commissionÂ¦ Â¦mo bi li sesÂ¦ Â¦everyÂ¦ Â¦e ur oÂ¦ Â¦toÂ¦ Â¦protectÂ¦ Â¦livesÂ¦ Â¦andÂ¦ Â¦li ve li h oo dsÂ¦
ğ‹‡Â¦toÂ¦ Â¦quicklyÂ¦ Â¦supportÂ¦ Â¦workersÂ¦ Â¦andÂ¦ Â¦mitigateÂ¦ Â¦theÂ¦ Â¦unemploymentÂ¦ Â¦ris ksÂ¦ Â¦thatÂ¦ Â¦comeÂ¦ Â¦withÂ¦ Â¦theÂ¦ ğ‹‡Â¦coronavirusÂ¦ Â¦outbreakÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦launchedÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦initi ativeÂ¦ Â¦calledÂ¦  â–-â– ğ‹‡ Â¦supportÂ¦ Â¦ mit ig atingÂ¦ ğ‹‡ Â¦unemploymentÂ¦ ğ‹‡ Â¦ris ksÂ¦ Â¦inÂ¦ ğ‹‡ Â¦emergencyÂ¦ .
Â¦scient istÂ¦ 
Â¦0 1Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦commissionÂ¦ Â¦scient istsÂ¦ Â¦developÂ¦ Â¦newÂ¦ Â¦controlÂ¦ Â¦materialÂ¦ Â¦forÂ¦ Â¦reliableÂ¦ ğ‹‡Â¦coronavirusÂ¦ - Â¦testingÂ¦ Â¦acrossÂ¦ Â¦theÂ¦ 
ğ‹‡ Â¦scient istsÂ¦ Â¦atÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦haveÂ¦ Â¦designedÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦controlÂ¦ Â¦materialÂ¦ Â¦thatÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦usedÂ¦ Â¦toÂ¦ Â¦acc ur atelyÂ¦ Â¦assessÂ¦ Â¦theÂ¦ Â¦fun c tion ingÂ¦ Â¦ofÂ¦ Â¦theirÂ¦ Â¦coronavirusÂ¦ Â¦testsÂ¦ Â¦andÂ¦ Â¦toÂ¦ Â¦avoidÂ¦ Â¦falseÂ¦ Â¦neg ativesÂ¦ .
Â¦lawÂ¦ 
Â¦31Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦presidentÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦war nsÂ¦ :â– ğ‹‡ Â¦emergencyÂ¦ ğ‹‡Â¦coronavirusÂ¦ Â¦measuresÂ¦ Â¦mustÂ¦ Â¦ resp ectÂ¦  Â¦fun d a mentalÂ¦ Â¦princ ip lesÂ¦ Â¦andÂ¦ Â¦val uesÂ¦
ğ‹‡Â¦overÂ¦ Â¦theÂ¦ Â¦pastÂ¦ Â¦weeksÂ¦ ,â– Â¦severalÂ¦  ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦haveÂ¦ Â¦takenÂ¦ Â¦emergencyÂ¦ Â¦measuresÂ¦ Â¦toÂ¦ Â¦addressÂ¦ Â¦theÂ¦ Â¦healthÂ¦ Â¦crisisÂ¦ Â¦causedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦coronavirusÂ¦ Â¦outbreakÂ¦ .
Â¦30Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2020Â¦ â–â€“â– Â¦la un chÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦d ed ic atedÂ¦ â– â€˜ ğ‹‡Â¦f igh tingÂ¦ Â¦dis infor mationÂ¦ â€™ â– Â¦s ectionÂ¦ Â¦linkedÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦outbreakÂ¦
ğ‹‡ Â¦mis infor mationÂ¦ Â¦andÂ¦ Â¦dis infor mationÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦healthÂ¦ Â¦spaceÂ¦ Â¦areÂ¦ Â¦th r ivingÂ¦ ,â– Â¦includingÂ¦ Â¦onÂ¦  - Â¦19Â¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦importantÂ¦ Â¦thatÂ¦ Â¦youÂ¦ Â¦r elyÂ¦ Â¦onlyÂ¦ Â¦onÂ¦ Â¦author it ativeÂ¦ Â¦sourcesÂ¦ Â¦toÂ¦ Â¦getÂ¦ Â¦updatedÂ¦ Â¦informationÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦isÂ¦ Â¦coordin atingÂ¦ Â¦aÂ¦ Â¦commonÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦outbreakÂ¦ .
ğ‹‡Â¦presidentÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦hasÂ¦ Â¦establishedÂ¦ Â¦aÂ¦ ğ‹‡Â¦coronavirusÂ¦ Â¦responseÂ¦ Â¦teamÂ¦ Â¦atÂ¦ Â¦politicalÂ¦ Â¦levelÂ¦ Â¦toÂ¦ Â¦coordin ateÂ¦ Â¦ourÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦
ğ‹‡Â¦duringÂ¦ Â¦theseÂ¦ Â¦timesÂ¦ Â¦ofÂ¦ Â¦crisisÂ¦ ,â– Â¦acrossÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦unionÂ¦ ,â– Â¦countriesÂ¦ ,â– Â¦regionsÂ¦ Â¦andÂ¦ Â¦citiesÂ¦ Â¦areÂ¦ Â¦stret chingÂ¦ Â¦outÂ¦ Â¦aÂ¦ Â¦help ingÂ¦ Â¦handÂ¦ Â¦toÂ¦ Â¦ne igh b oursÂ¦ Â¦andÂ¦ Â¦assistanceÂ¦ Â¦isÂ¦ Â¦givenÂ¦ Â¦toÂ¦ Â¦thoseÂ¦ Â¦mostÂ¦ Â¦inÂ¦ Â¦needÂ¦ :â– Â¦don ationsÂ¦ Â¦ofÂ¦ Â¦protectiveÂ¦ Â¦equipmentÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦masksÂ¦ ,â– Â¦crossÂ¦ - Â¦borderÂ¦ Â¦treatmentsÂ¦ Â¦ofÂ¦ Â¦illÂ¦ Â¦patientsÂ¦ Â¦andÂ¦ Â¦bringingÂ¦ Â¦strandedÂ¦ Â¦citizensÂ¦ Â¦homeÂ¦ .
ğ‹‡ Â¦safeÂ¦  - Â¦19Â¦ Â¦vaccinesÂ¦ Â¦forÂ¦ ğ‹‡Â¦e ur op e ansÂ¦
ğ‹‡Â¦aÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ Â¦vaccineÂ¦ Â¦isÂ¦ Â¦ourÂ¦ Â¦bestÂ¦ Â¦chanceÂ¦ Â¦toÂ¦ Â¦b eatÂ¦ Â¦coronavirusÂ¦ Â¦andÂ¦ Â¦returnÂ¦ Â¦toÂ¦ Â¦ourÂ¦ Â¦normalÂ¦ Â¦livesÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦workingÂ¦ Â¦ti re le ss lyÂ¦ Â¦toÂ¦ Â¦sec ureÂ¦ Â¦dosesÂ¦ Â¦ofÂ¦ Â¦potentialÂ¦ Â¦vaccinesÂ¦ ,â– Â¦thatÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦sharedÂ¦ Â¦withÂ¦ Â¦allÂ¦ .
Â¦4Â¦ ğ‹‡ Â¦juneÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡Â¦theÂ¦  Â¦pro po sesÂ¦ Â¦aÂ¦ Â¦strongÂ¦ Â¦mult i la te ralÂ¦ Â¦tradeÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦
ğ‹‡Â¦theÂ¦  Â¦hasÂ¦ Â¦sub mit tedÂ¦ Â¦itsÂ¦ Â¦prop os alÂ¦ Â¦see kingÂ¦ Â¦theÂ¦ Â¦com mit mentÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦worldÂ¦ ğ‹‡ Â¦tradeÂ¦ ğ‹‡ Â¦organizationÂ¦ Â¦membersÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦mult i la te ralÂ¦ Â¦tradeÂ¦ Â¦actionÂ¦ Â¦planÂ¦ Â¦toÂ¦ Â¦exp andÂ¦ Â¦theÂ¦ Â¦productionÂ¦ Â¦ofÂ¦  - Â¦19Â¦ Â¦vaccinesÂ¦ Â¦andÂ¦ Â¦treatmentsÂ¦ .
Â¦manÂ¦ Â¦h ol dingÂ¦ Â¦aÂ¦ Â¦lea f l etÂ¦ 
Â¦21Â¦ ğ‹‡ Â¦decemberÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦author i sesÂ¦ Â¦firstÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦gr an tedÂ¦ Â¦aÂ¦ Â¦con di tionalÂ¦ Â¦mar ke tingÂ¦ Â¦author isationÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  â€‘ Â¦19Â¦ Â¦developedÂ¦ Â¦byÂ¦  Â¦andÂ¦ ğ‹‡ Â¦pfizerÂ¦ .
Â¦vaccineÂ¦ 
Â¦17Â¦ ğ‹‡ Â¦decemberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦presidentÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦an no un cesÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦vaccinationÂ¦ Â¦daysÂ¦ Â¦onÂ¦ Â¦27Â¦ ,â– Â¦28Â¦ Â¦andÂ¦ Â¦29Â¦ ğ‹‡ Â¦decemberÂ¦
ğ‹‡Â¦inÂ¦ Â¦caseÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦successfulÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ Â¦vaccineÂ¦ Â¦author isationÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦medicinesÂ¦ ğ‹‡ Â¦agencyÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ ,â– ğ‹‡Â¦presidentÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦announcedÂ¦ Â¦thatÂ¦ Â¦onÂ¦ Â¦27Â¦ ,â– Â¦28Â¦ Â¦andÂ¦ Â¦29Â¦ ğ‹‡ Â¦decemberÂ¦ Â¦vaccinationÂ¦ Â¦againstÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦willÂ¦ Â¦startÂ¦ Â¦acrossÂ¦ Â¦theÂ¦  .
Â¦w omanÂ¦ Â¦inÂ¦ Â¦frontÂ¦ Â¦ofÂ¦  Â¦commissionÂ¦ Â¦buildingÂ¦ Â¦l ookingÂ¦ Â¦atÂ¦ Â¦herÂ¦ Â¦s ma rt ph oneÂ¦ 
Â¦14Â¦ ğ‹‡ Â¦decemberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦commissionÂ¦ Â¦la un chesÂ¦ ğ‹‡ Â¦reÂ¦ - Â¦openÂ¦  Â¦mobileÂ¦ Â¦appÂ¦ Â¦withÂ¦ Â¦regularÂ¦ Â¦updatesÂ¦ Â¦onÂ¦ Â¦coronavirusÂ¦ Â¦healthÂ¦ ,â– Â¦safetyÂ¦ Â¦andÂ¦ Â¦travelÂ¦ Â¦measuresÂ¦ Â¦acrossÂ¦ ğ‹‡ Â¦europeÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦launchedÂ¦ Â¦theÂ¦ Â¦freeÂ¦ ğ‹‡ Â¦reÂ¦ - Â¦openÂ¦  Â¦mobileÂ¦ Â¦appÂ¦ ,â– Â¦providingÂ¦ Â¦comprehensiveÂ¦ ,â– Â¦upÂ¦ - Â¦toÂ¦ - Â¦dateÂ¦ Â¦informationÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦healthÂ¦ ,â– Â¦safetyÂ¦ Â¦andÂ¦ Â¦travelÂ¦ Â¦measuresÂ¦ Â¦inÂ¦ Â¦allÂ¦  ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦andÂ¦ ğ‹‡Â¦i ce landÂ¦ ,â– ğ‹‡Â¦l ie ch t ens te inÂ¦ ,â– ğ‹‡ Â¦nor wayÂ¦ Â¦andÂ¦ ğ‹‡ Â¦swit z er landÂ¦ .
ğ‹‡ Â¦europeanÂ¦ Â¦dem oc r acyÂ¦ Â¦actionÂ¦ Â¦planÂ¦ 
Â¦3Â¦ ğ‹‡ Â¦decemberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦dem oc r acyÂ¦ ğ‹‡ Â¦actionÂ¦ ğ‹‡ Â¦planÂ¦ :â– Â¦makingÂ¦  Â¦dem oc r ac iesÂ¦ Â¦stro ngerÂ¦
ğ‹‡Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦ Â¦hasÂ¦ Â¦h igh l igh tedÂ¦ Â¦challen gesÂ¦ Â¦toÂ¦ Â¦theÂ¦  Â¦dem oc r ac iesÂ¦ .
ğ‹‡ Â¦maskÂ¦ Â¦andÂ¦  Â¦f la gÂ¦ 
Â¦2Â¦ ğ‹‡ Â¦decemberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦commissionÂ¦ Â¦pres entsÂ¦ â–â€œ ğ‹‡ Â¦stayingÂ¦ Â¦safeÂ¦ Â¦fromÂ¦  - Â¦19Â¦ Â¦duringÂ¦ Â¦w in terÂ¦ â€ â– Â¦strategyÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦adop tedÂ¦ Â¦aÂ¦ Â¦strategyÂ¦ Â¦forÂ¦ Â¦sus tain ablyÂ¦ Â¦manag ingÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ Â¦overÂ¦ Â¦theÂ¦ Â¦comingÂ¦ Â¦w in terÂ¦ Â¦monthsÂ¦ ,â– Â¦whenÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦transmissionÂ¦ Â¦riskÂ¦ Â¦mayÂ¦ Â¦increaseÂ¦ Â¦ owingÂ¦ Â¦toÂ¦ Â¦indoorÂ¦ Â¦gatheringsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦strategyÂ¦ Â¦recommendsÂ¦ Â¦continuedÂ¦ Â¦v ig il anceÂ¦ Â¦andÂ¦ Â¦ca utionÂ¦ Â¦throughoutÂ¦ Â¦theÂ¦ Â¦w in terÂ¦ Â¦periodÂ¦ Â¦andÂ¦ Â¦intoÂ¦ Â¦2021Â¦ Â¦whenÂ¦ Â¦theÂ¦ Â¦r ol lÂ¦ Â¦outÂ¦ Â¦ofÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ Â¦vaccinesÂ¦ Â¦willÂ¦ Â¦occurÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦coordin atedÂ¦  - Â¦wideÂ¦ Â¦approachÂ¦ Â¦isÂ¦ Â¦keyÂ¦ Â¦toÂ¦ Â¦avoidÂ¦ Â¦aÂ¦ Â¦res ur g enceÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ ,â– Â¦andÂ¦ Â¦anyÂ¦ Â¦rela x ationÂ¦ Â¦ofÂ¦ Â¦measuresÂ¦ Â¦shouldÂ¦ Â¦takeÂ¦ Â¦intoÂ¦ Â¦ac coun tÂ¦ Â¦theÂ¦ Â¦evolutionÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦epidemiologicalÂ¦ Â¦situationÂ¦ .
Â¦1Â¦ ğ‹‡ Â¦decemberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦dis b ur sesÂ¦ â–â‚¬ Â¦8Â¦ . Â¦5Â¦ Â¦billionÂ¦ Â¦underÂ¦  Â¦toÂ¦ Â¦fiveÂ¦ ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦toÂ¦ Â¦helpÂ¦ Â¦sus tainÂ¦ Â¦jobsÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦dis b ur sedÂ¦ â–â‚¬ Â¦8Â¦ .
ğ‹‡ Â¦ph ar maÂ¦ Â¦strategyÂ¦ 
Â¦25Â¦ ğ‹‡ Â¦novemberÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦ph ar m ac eut icalÂ¦ ğ‹‡ Â¦strategyÂ¦ Â¦forÂ¦ ğ‹‡ Â¦europeÂ¦ :â– Â¦aff ord ableÂ¦ ,â– Â¦acc es sibleÂ¦ Â¦andÂ¦ Â¦safeÂ¦ Â¦medicinesÂ¦ Â¦forÂ¦ Â¦allÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦adop tedÂ¦ Â¦aÂ¦ ğ‹‡ Â¦ph ar m ac eut icalÂ¦ ğ‹‡ Â¦strategyÂ¦ Â¦forÂ¦ ğ‹‡ Â¦europeÂ¦ Â¦toÂ¦ Â¦ensureÂ¦ Â¦thatÂ¦ Â¦everyoneÂ¦ Â¦willÂ¦ Â¦haveÂ¦ Â¦accessÂ¦ Â¦toÂ¦ Â¦in n ov ativeÂ¦ Â¦andÂ¦ Â¦aff ord ableÂ¦ Â¦medicinesÂ¦ Â¦whileÂ¦ Â¦suppor tingÂ¦ Â¦comp e ti ti ve nessÂ¦ ,â– Â¦in n ov ationÂ¦ Â¦andÂ¦ Â¦sus tain a bilityÂ¦ Â¦ofÂ¦ Â¦theÂ¦  â€™ Â¦sÂ¦ Â¦ph ar m ac eut icalÂ¦ Â¦industryÂ¦ .
ğ‹‡ Â¦rapidÂ¦ Â¦testsÂ¦ 
Â¦18Â¦ ğ‹‡ Â¦novemberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦stepsÂ¦ Â¦upÂ¦ Â¦actionsÂ¦ Â¦onÂ¦ Â¦testingÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦recomm end ationÂ¦ Â¦onÂ¦ Â¦rapidÂ¦ Â¦antigenÂ¦ Â¦testsÂ¦ Â¦andÂ¦ Â¦supportÂ¦ Â¦toÂ¦ Â¦increaseÂ¦ Â¦testingÂ¦ Â¦capacityÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦adop tedÂ¦ Â¦aÂ¦ Â¦recomm end ationÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦useÂ¦ Â¦ofÂ¦ Â¦rapidÂ¦ Â¦antigenÂ¦ Â¦testsÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦diagnosisÂ¦ Â¦ofÂ¦  - Â¦19Â¦ Â¦withÂ¦ Â¦theÂ¦ Â¦ai mÂ¦ Â¦ofÂ¦ Â¦ ens uringÂ¦ Â¦theÂ¦ Â¦freeÂ¦ Â¦movementÂ¦ Â¦ofÂ¦ Â¦peopleÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦s m oo thÂ¦ Â¦fun c tion ingÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦inter n alÂ¦ Â¦marketÂ¦ 
Â¦17Â¦ ğ‹‡ Â¦novemberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦dis b ur sesÂ¦ â–â‚¬ Â¦14Â¦ Â¦billionÂ¦ Â¦underÂ¦  Â¦toÂ¦ Â¦n ineÂ¦ ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦toÂ¦ Â¦helpÂ¦ Â¦sus tainÂ¦ Â¦jobsÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦dis b ur sedÂ¦ â–â‚¬ Â¦14Â¦ Â¦billionÂ¦ Â¦toÂ¦ Â¦n ineÂ¦  Â¦countriesÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦secondÂ¦ Â¦inst al mentÂ¦ Â¦ofÂ¦ Â¦financialÂ¦ Â¦supportÂ¦ Â¦toÂ¦ ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦underÂ¦ Â¦theÂ¦  Â¦inst ru mentÂ¦ .
ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦healthÂ¦ ğ‹‡ Â¦unionÂ¦ 
Â¦11Â¦ ğ‹‡ Â¦novemberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦takesÂ¦ Â¦firstÂ¦ Â¦stepsÂ¦ Â¦towardsÂ¦ Â¦buildingÂ¦ Â¦aÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦healthÂ¦ ğ‹‡ Â¦unionÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦isÂ¦ Â¦put tingÂ¦ Â¦for w ardÂ¦ Â¦aÂ¦ Â¦setÂ¦ Â¦ofÂ¦ Â¦prop os alsÂ¦ Â¦toÂ¦ Â¦strengthenÂ¦ Â¦theÂ¦  ' Â¦sÂ¦ Â¦healthÂ¦ Â¦securityÂ¦ Â¦fra me workÂ¦ ,â– Â¦andÂ¦ Â¦toÂ¦ Â¦re infor ceÂ¦ Â¦theÂ¦ Â¦crisisÂ¦ Â¦preparednessÂ¦ Â¦andÂ¦ Â¦responseÂ¦ Â¦roleÂ¦ Â¦ofÂ¦ Â¦keyÂ¦  Â¦agenciesÂ¦ .
 
Â¦10Â¦ ğ‹‡ Â¦novemberÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦w el co mesÂ¦ Â¦a gr ee mentÂ¦ Â¦onÂ¦ â–â‚¬ Â¦1Â¦ . Â¦8Â¦ Â¦tri ll ionÂ¦  Â¦longÂ¦ - Â¦termÂ¦ Â¦b ud g etÂ¦ Â¦andÂ¦  Â¦toÂ¦ Â¦helpÂ¦ Â¦bu i ldÂ¦ Â¦gr ee nerÂ¦ ,â– Â¦moreÂ¦ Â¦digitalÂ¦ Â¦andÂ¦ Â¦moreÂ¦ Â¦re si li entÂ¦ ğ‹‡ Â¦europeÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦parliamentÂ¦ Â¦andÂ¦  ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡ Â¦councilÂ¦ Â¦haveÂ¦ Â¦agreedÂ¦ Â¦onÂ¦ Â¦theÂ¦  â€™ Â¦sÂ¦ Â¦longÂ¦ - Â¦termÂ¦ Â¦b ud g etÂ¦ Â¦andÂ¦  .
ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦economicÂ¦ ğ‹‡ Â¦for ec astÂ¦ Â¦figuresÂ¦ 
Â¦5Â¦ ğ‹‡ Â¦novemberÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦aut um nÂ¦ Â¦2020Â¦ ğ‹‡ Â¦economicÂ¦ ğ‹‡ Â¦for ec astÂ¦
ğ‹‡Â¦theÂ¦ Â¦economicÂ¦ Â¦impactÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ Â¦hasÂ¦ Â¦diff eredÂ¦ Â¦widelyÂ¦ Â¦acrossÂ¦ Â¦theÂ¦  .
Â¦w omanÂ¦ Â¦h ol dingÂ¦ Â¦aÂ¦ Â¦phoneÂ¦ 
Â¦28Â¦ ğ‹‡ Â¦octoberÂ¦ â–â€“â– ğ‹‡Â¦t ac k lingÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦res ur g enceÂ¦ :â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦s etsÂ¦ Â¦outÂ¦ Â¦newÂ¦ Â¦actionsÂ¦ Â¦toÂ¦ Â¦re infor ceÂ¦ Â¦preparednessÂ¦ Â¦andÂ¦ Â¦responseÂ¦ Â¦measuresÂ¦ Â¦acrossÂ¦ Â¦theÂ¦ 
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦setÂ¦ Â¦outÂ¦ Â¦co nc re teÂ¦ Â¦actionsÂ¦ Â¦inÂ¦ Â¦aÂ¦ ğ‹‡ Â¦commun icationÂ¦ Â¦onÂ¦ Â¦additionalÂ¦  - Â¦19Â¦ Â¦responseÂ¦ Â¦measuresÂ¦ Â¦toÂ¦ Â¦helpÂ¦ Â¦limitÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ ,â– Â¦sa veÂ¦ Â¦livesÂ¦ Â¦andÂ¦ Â¦bu i ldÂ¦ Â¦increasedÂ¦ Â¦re si li enceÂ¦ Â¦acrossÂ¦ Â¦severalÂ¦ Â¦areasÂ¦ Â¦inÂ¦ Â¦allÂ¦ ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ .
ğ‹‡Â¦firstÂ¦ Â¦dis b ur se mentsÂ¦ Â¦underÂ¦  Â¦financialÂ¦ Â¦supportÂ¦ 
Â¦27Â¦ ğ‹‡ Â¦octoberÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦commissionÂ¦ Â¦dis b ur sesÂ¦ Â¦aÂ¦ Â¦firstÂ¦ â–â‚¬ Â¦17Â¦ Â¦billionÂ¦  Â¦inst al mentsÂ¦ Â¦toÂ¦ ğ‹‡ Â¦italyÂ¦ ,â– ğ‹‡ Â¦spainÂ¦ Â¦andÂ¦ ğ‹‡ Â¦po landÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦dis b ur sedÂ¦ Â¦aÂ¦ Â¦totalÂ¦ Â¦ofÂ¦ â–â‚¬ Â¦17Â¦ Â¦billionÂ¦ Â¦toÂ¦ ğ‹‡ Â¦italyÂ¦ â–( â‚¬ Â¦10Â¦ Â¦billionÂ¦ ),â– ğ‹‡ Â¦spainÂ¦ â–( â‚¬ Â¦6Â¦ Â¦billionÂ¦ )â– Â¦andÂ¦ ğ‹‡ Â¦po landÂ¦ â–( â‚¬ Â¦1Â¦ Â¦billionÂ¦ )â– Â¦inÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦inst al mentÂ¦ Â¦ofÂ¦  Â¦financialÂ¦ Â¦supportÂ¦ Â¦toÂ¦ ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ .
Â¦manÂ¦ Â¦l ookingÂ¦ Â¦atÂ¦ Â¦s ma rt ph oneÂ¦ Â¦inÂ¦  
Â¦19Â¦ ğ‹‡ Â¦octoberÂ¦ Â¦2020Â¦ â–-â–  Â¦inter op e ra bilityÂ¦ Â¦ga te wayÂ¦ Â¦go esÂ¦ Â¦liveÂ¦ ,â– Â¦firstÂ¦ Â¦contactÂ¦ Â¦tracingÂ¦ Â¦andÂ¦ Â¦war ningÂ¦ Â¦appsÂ¦ Â¦linkedÂ¦ Â¦toÂ¦ Â¦theÂ¦  - Â¦systemÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ ,â– Â¦atÂ¦ Â¦theÂ¦ Â¦in vi tationÂ¦ Â¦byÂ¦  ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ ,â– Â¦hasÂ¦ Â¦setÂ¦ Â¦upÂ¦ Â¦anÂ¦  - Â¦wideÂ¦ Â¦systemÂ¦ Â¦toÂ¦ Â¦ensureÂ¦ Â¦thatÂ¦ Â¦coronavirusÂ¦ Â¦contactÂ¦ Â¦andÂ¦ Â¦tracingÂ¦ Â¦appsÂ¦ Â¦canÂ¦ â– â€˜ Â¦talkÂ¦ Â¦toÂ¦ Â¦eachÂ¦ Â¦otherÂ¦ â€™ .
ğ‹‡Â¦aÂ¦ Â¦scient istÂ¦ Â¦workingÂ¦ Â¦atÂ¦ Â¦aÂ¦ Â¦screenÂ¦ 
Â¦15Â¦ ğ‹‡ Â¦octoberÂ¦ Â¦2020Â¦ â–â€“â–  Â¦vaccineÂ¦ Â¦strategyÂ¦ :â– Â¦preparednessÂ¦ Â¦forÂ¦  - Â¦19Â¦ Â¦vaccinationÂ¦ Â¦strategiesÂ¦ Â¦andÂ¦ Â¦vaccineÂ¦ Â¦dep lo y mentÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦publishedÂ¦ Â¦aÂ¦ ğ‹‡ Â¦commun icationÂ¦ Â¦onÂ¦ Â¦preparednessÂ¦ Â¦forÂ¦  - Â¦19Â¦ Â¦vaccinationÂ¦ Â¦strategiesÂ¦ Â¦andÂ¦ Â¦vaccineÂ¦ Â¦dep lo y mentÂ¦ .
Â¦twoÂ¦ Â¦peopleÂ¦ Â¦withÂ¦ Â¦ lu gg ageÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦tra inÂ¦ Â¦s tationÂ¦ 
Â¦13Â¦ ğ‹‡ Â¦octoberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦a gr ee mentÂ¦ Â¦onÂ¦ Â¦aÂ¦ Â¦coordin atedÂ¦ Â¦approachÂ¦ Â¦toÂ¦ Â¦measuresÂ¦ Â¦restrictingÂ¦ Â¦freeÂ¦ Â¦movementÂ¦ Â¦inÂ¦ Â¦theÂ¦  Â¦inÂ¦ Â¦v iewÂ¦ Â¦ofÂ¦  - Â¦19Â¦
 ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦haveÂ¦ Â¦agreedÂ¦ Â¦onÂ¦ Â¦aÂ¦ Â¦coordin atedÂ¦ Â¦approachÂ¦ Â¦toÂ¦ Â¦travelÂ¦ Â¦restrictionsÂ¦ Â¦linkedÂ¦ Â¦toÂ¦ Â¦theÂ¦  - Â¦19Â¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦moreÂ¦ Â¦informationÂ¦
Â¦13Â¦ ğ‹‡ Â¦billionÂ¦ Â¦figureÂ¦ Â¦ ic onÂ¦ Â¦forÂ¦  
Â¦12Â¦ ğ‹‡ Â¦octoberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦firstÂ¦ Â¦resultsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦implement ationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦coronavirusÂ¦ ğ‹‡ Â¦responseÂ¦ ğ‹‡ Â¦in ve st mentÂ¦ ğ‹‡ Â¦initi ativesÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦releasedÂ¦ Â¦theÂ¦ Â¦provi si onalÂ¦ Â¦firstÂ¦ Â¦resultsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦coronavirusÂ¦ ğ‹‡ Â¦responseÂ¦ ğ‹‡ Â¦in ve st mentÂ¦ ğ‹‡ Â¦initi ativesÂ¦ :â– Â¦theÂ¦  Â¦m ob il isedÂ¦ Â¦overÂ¦ â–â‚¬ Â¦13Â¦ Â¦billionÂ¦ Â¦toÂ¦ Â¦t ac k leÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦ .
 - Â¦19Â¦ 
Â¦8Â¦ ğ‹‡ Â¦octoberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦appro vesÂ¦ Â¦thirdÂ¦ Â¦contr actÂ¦ Â¦forÂ¦ Â¦potentialÂ¦  - Â¦19Â¦ Â¦vaccinesÂ¦ Â¦andÂ¦ Â¦signsÂ¦ ğ‹‡ Â¦remdesivirÂ¦ Â¦dealÂ¦
ğ‹‡Â¦onÂ¦ Â¦7Â¦ ğ‹‡ Â¦octoberÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦approvedÂ¦ Â¦aÂ¦ Â¦thirdÂ¦ Â¦contr actÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦ph ar m ac eut icalÂ¦ Â¦com pa nyÂ¦ ,â– ğ‹‡ Â¦j an ss enÂ¦ ğ‹‡ Â¦ph ar m ac eut ic aÂ¦  ,â– Â¦forÂ¦ Â¦vaccineÂ¦ Â¦dosesÂ¦ Â¦forÂ¦ Â¦200Â¦ Â¦millionÂ¦ Â¦peopleÂ¦ .
Â¦stockÂ¦ Â¦numbersÂ¦ 
Â¦7Â¦ ğ‹‡ Â¦octoberÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦toÂ¦ Â¦issueÂ¦   Â¦b on dsÂ¦ Â¦ofÂ¦ Â¦upÂ¦ Â¦toÂ¦ â–â‚¬ Â¦100Â¦ Â¦billionÂ¦ Â¦asÂ¦ Â¦socialÂ¦ Â¦b on dsÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦announcedÂ¦ Â¦thatÂ¦ Â¦itÂ¦ Â¦willÂ¦ Â¦issueÂ¦   Â¦socialÂ¦ Â¦b on dsÂ¦ Â¦ofÂ¦ Â¦upÂ¦ Â¦toÂ¦ â–â‚¬ Â¦100Â¦ Â¦billionÂ¦ Â¦andÂ¦ Â¦thatÂ¦ Â¦itÂ¦ Â¦hasÂ¦ Â¦adop tedÂ¦ Â¦anÂ¦ Â¦inde p en de ntlyÂ¦ Â¦evalu atedÂ¦ ğ‹‡Â¦socialÂ¦ ğ‹‡Â¦b on dÂ¦ ğ‹‡ Â¦fra me workÂ¦ .
ğ‹‡Â¦ru leÂ¦ Â¦ofÂ¦ Â¦lawÂ¦ Â¦reportÂ¦ 
Â¦30Â¦ ğ‹‡ Â¦septemberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦commissionÂ¦ Â¦un ve ilsÂ¦ Â¦firstÂ¦ - Â¦e verÂ¦ Â¦ru leÂ¦ Â¦ofÂ¦ Â¦lawÂ¦ Â¦reportÂ¦ :â– Â¦coronavirusÂ¦ Â¦emergencyÂ¦ Â¦measuresÂ¦ Â¦mustÂ¦ Â¦ resp ectÂ¦  â€™ Â¦sÂ¦ Â¦fun d a mentalÂ¦ Â¦princ ip lesÂ¦ Â¦andÂ¦ Â¦val uesÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦presentedÂ¦ Â¦itsÂ¦ Â¦firstÂ¦  - Â¦wideÂ¦ ğ‹‡Â¦ru leÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦lawÂ¦ ğ‹‡ Â¦reportÂ¦ ,â– Â¦aÂ¦ Â¦newÂ¦ Â¦preventiveÂ¦ Â¦t oolÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦heartÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦newÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦ru leÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦lawÂ¦ ğ‹‡ Â¦mechan ismÂ¦ .
ğ‹‡Â¦s te ll aÂ¦ ğ‹‡ Â¦k y r ia k i desÂ¦  Â¦meetingÂ¦ 
Â¦24Â¦ ğ‹‡ Â¦septemberÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦newÂ¦  Â¦riskÂ¦ Â¦assessmentÂ¦ Â¦callsÂ¦ Â¦forÂ¦ Â¦str ic terÂ¦ Â¦measuresÂ¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦increasedÂ¦ Â¦infectionÂ¦ Â¦ratesÂ¦
ğ‹‡Â¦theÂ¦  Â¦hasÂ¦ Â¦itsÂ¦ Â¦updatedÂ¦ Â¦rapidÂ¦ Â¦riskÂ¦ Â¦assessmentÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦developmentÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦epidemiologicalÂ¦ Â¦situationÂ¦ Â¦andÂ¦ Â¦f in dsÂ¦ Â¦thatÂ¦ Â¦infectionÂ¦ Â¦ratesÂ¦ Â¦haveÂ¦ Â¦increasedÂ¦ Â¦acrossÂ¦ Â¦theÂ¦  Â¦andÂ¦ Â¦theÂ¦  .
ğ‹‡Â¦anÂ¦ Â¦employ e eÂ¦ Â¦isÂ¦ Â¦contro llingÂ¦ Â¦aÂ¦ Â¦ma ch ineÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦fa ct oryÂ¦ 
Â¦22Â¦ ğ‹‡ Â¦septemberÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦commissionÂ¦ Â¦w el co mesÂ¦ Â¦f in al isationÂ¦ Â¦ofÂ¦ Â¦gu ar an te eÂ¦ Â¦systemÂ¦ Â¦forÂ¦ â–â‚¬ Â¦100Â¦ Â¦billionÂ¦  Â¦inst ru mentÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦w el co mesÂ¦ Â¦theÂ¦ Â¦activ ationÂ¦ Â¦ofÂ¦ Â¦theÂ¦  â–-â– Â¦theÂ¦ Â¦temporaryÂ¦ ğ‹‡ Â¦supportÂ¦ Â¦ mit ig atingÂ¦ ğ‹‡ Â¦unemploymentÂ¦ ğ‹‡ Â¦ris ksÂ¦ Â¦inÂ¦ ğ‹‡ Â¦emergencyÂ¦ Â¦inst ru mentÂ¦ ,â– Â¦whichÂ¦ Â¦willÂ¦ Â¦provideÂ¦ Â¦upÂ¦ Â¦toÂ¦ â–â‚¬ Â¦100Â¦ Â¦billionÂ¦ Â¦inÂ¦ Â¦financialÂ¦ Â¦supportÂ¦ Â¦toÂ¦ Â¦helpÂ¦ Â¦protectÂ¦ Â¦workersÂ¦ Â¦andÂ¦ Â¦jobsÂ¦ Â¦affectedÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦ .
ğ‹‡ Â¦nextÂ¦ ğ‹‡ Â¦gener ationÂ¦  
Â¦17Â¦ ğ‹‡ Â¦septemberÂ¦ Â¦2020Â¦ â–-â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦pres entsÂ¦ Â¦nextÂ¦ Â¦stepsÂ¦ Â¦forÂ¦ â–â‚¬ Â¦6 7 2Â¦ . Â¦5Â¦ Â¦billionÂ¦ ğ‹‡ Â¦recoveryÂ¦ Â¦andÂ¦ ğ‹‡ Â¦re si li enceÂ¦ ğ‹‡ Â¦facilityÂ¦ Â¦inÂ¦ Â¦2021Â¦ ğ‹‡ Â¦annualÂ¦ ğ‹‡ Â¦sus tain ableÂ¦ ğ‹‡ Â¦growthÂ¦ ğ‹‡ Â¦strategyÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦setÂ¦ Â¦outÂ¦ Â¦guidanceÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦implement ationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦recoveryÂ¦ Â¦andÂ¦ ğ‹‡ Â¦re si li enceÂ¦ ğ‹‡ Â¦facilityÂ¦ Â¦inÂ¦ Â¦itsÂ¦ Â¦2021Â¦ ğ‹‡ Â¦annualÂ¦ ğ‹‡ Â¦sus tain ableÂ¦ ğ‹‡ Â¦growthÂ¦ ğ‹‡ Â¦strategyÂ¦ .
ğ‹‡ Â¦twoÂ¦ Â¦scient istsÂ¦ Â¦workingÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦la bÂ¦ 
Â¦10Â¦ ğ‹‡ Â¦septemberÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğ‹‡ Â¦worldÂ¦ ğ‹‡Â¦healthÂ¦ ğ‹‡ Â¦organ isationÂ¦ Â¦toÂ¦ Â¦strengthenÂ¦ Â¦coronavirusÂ¦ Â¦treatmentsÂ¦ Â¦inÂ¦ Â¦globalÂ¦ Â¦col la bor ationÂ¦
ğ‹‡ Â¦todayÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦presidentÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ ,â– ğ‹‡ Â¦u rs ulaÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ ,â– Â¦andÂ¦ Â¦theÂ¦ ğ‹‡ Â¦directorÂ¦ ğ‹‡ Â¦generalÂ¦ Â¦ofÂ¦ Â¦theÂ¦  ,â– ğ‹‡ Â¦tedrosÂ¦ ğ‹‡ Â¦ad han omÂ¦ ğ‹‡Â¦g he b re y es usÂ¦ ,â– Â¦launchedÂ¦ Â¦andÂ¦ Â¦c oÂ¦ - Â¦h os tedÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦meetingÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦highÂ¦ ğ‹‡ Â¦levelÂ¦ ğ‹‡ Â¦fa ci li tationÂ¦ ğ‹‡ Â¦councilÂ¦ Â¦toÂ¦ Â¦sp e edÂ¦ Â¦upÂ¦ Â¦theÂ¦ Â¦developmentÂ¦ Â¦andÂ¦ Â¦dep lo y mentÂ¦ Â¦ofÂ¦ Â¦vaccinesÂ¦ ,â– Â¦testsÂ¦ Â¦andÂ¦ Â¦treatmentsÂ¦ Â¦againstÂ¦  - Â¦19Â¦ .
Â¦vaccinesÂ¦ 
Â¦9Â¦ ğ‹‡ Â¦septemberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦commissionÂ¦ Â¦ad dsÂ¦ Â¦toÂ¦ Â¦vaccinesÂ¦ Â¦port f o lioÂ¦ Â¦followingÂ¦ Â¦t al ksÂ¦ Â¦withÂ¦  - ğ‹‡ Â¦pfizerÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦conclu dedÂ¦ Â¦expl or atoryÂ¦ Â¦t al ksÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦si x thÂ¦ Â¦manufactur erÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦potentialÂ¦ Â¦pur ch aseÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦ .
Â¦tra vel erÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦tra inÂ¦ Â¦s tationÂ¦ 
Â¦4Â¦ ğ‹‡ Â¦septemberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦pro po sesÂ¦ Â¦toÂ¦ Â¦har mon iseÂ¦ Â¦nationalÂ¦ Â¦measuresÂ¦ Â¦affectingÂ¦ Â¦freeÂ¦ Â¦movementÂ¦ Â¦inÂ¦ Â¦theÂ¦ 
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦adop tedÂ¦ Â¦aÂ¦ Â¦prop os alÂ¦ Â¦forÂ¦ Â¦aÂ¦ ğ‹‡ Â¦councilÂ¦ ğ‹‡ Â¦recomm end ationÂ¦ Â¦toÂ¦ Â¦improveÂ¦ Â¦theÂ¦ Â¦coordin ationÂ¦ Â¦andÂ¦ Â¦commun icationÂ¦ Â¦ofÂ¦ Â¦measuresÂ¦ Â¦thatÂ¦ Â¦restrictÂ¦ Â¦freeÂ¦ Â¦movementÂ¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦ .
Â¦27Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2021Â¦ â–-â–  Â¦c han n elsÂ¦ Â¦criticalÂ¦ Â¦supportÂ¦ Â¦toÂ¦ ğ‹‡ Â¦indiaÂ¦ Â¦viaÂ¦  ğ‹‡Â¦c iv ilÂ¦ ğ‹‡ Â¦protectionÂ¦ ğ‹‡ Â¦mechan ismÂ¦
ğ‹‡Â¦aÂ¦ Â¦sh ip mentÂ¦ Â¦ofÂ¦ Â¦ur ge ntlyÂ¦ Â¦neededÂ¦ Â¦oxygenÂ¦ ,â– Â¦medicineÂ¦ Â¦andÂ¦ Â¦equipmentÂ¦ Â¦willÂ¦ Â¦beÂ¦ Â¦del iv eredÂ¦ Â¦overÂ¦ Â¦theÂ¦ Â¦comingÂ¦ Â¦daysÂ¦ Â¦byÂ¦  ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦toÂ¦ ğ‹‡ Â¦indiaÂ¦ ,â– Â¦followingÂ¦ Â¦theÂ¦ Â¦countryÂ¦ ' Â¦sÂ¦ Â¦requestÂ¦ Â¦forÂ¦ Â¦supportÂ¦ .
ğ‹‡Â¦b er la y mon tÂ¦ 
Â¦16Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2021Â¦ â–- â–â‚¬ Â¦5 6 2Â¦ . Â¦5Â¦ Â¦millionÂ¦ Â¦inÂ¦  -  Â¦in ve st mentÂ¦ Â¦fundingÂ¦ Â¦all oc atedÂ¦ Â¦toÂ¦ ğ‹‡ Â¦bul g ar iaÂ¦ ,â– ğ‹‡Â¦fin landÂ¦ ,â– ğ‹‡ Â¦franceÂ¦ Â¦andÂ¦ ğ‹‡ Â¦li th u a niaÂ¦
 -  Â¦in ve st mentsÂ¦ Â¦ofÂ¦ Â¦aroundÂ¦ â–â‚¬ Â¦5 6 2Â¦ .
ğ‹‡Â¦presidentÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ 
Â¦14Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2021Â¦ â–-â– Â¦100Â¦ Â¦millionÂ¦ Â¦vaccinationsÂ¦ Â¦againstÂ¦  - Â¦19Â¦ Â¦inÂ¦ Â¦theÂ¦ 
ğ‹‡Â¦presidentÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦saidÂ¦ : â–â€œ ğ‹‡ Â¦vaccinationÂ¦ Â¦isÂ¦ Â¦p ic kingÂ¦ Â¦upÂ¦ Â¦sp e edÂ¦ Â¦acrossÂ¦ ğ‹‡ Â¦europeÂ¦  ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦haveÂ¦ Â¦receivedÂ¦ Â¦overÂ¦ Â¦12 6Â¦ Â¦millionÂ¦ Â¦dosesÂ¦ Â¦ofÂ¦ Â¦vaccinesÂ¦ Â¦asÂ¦ Â¦ofÂ¦ Â¦y ester dayÂ¦ .
ğ‹‡ Â¦pi ct ureÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦b er la y mon tÂ¦ Â¦fa ca deÂ¦ 
Â¦14Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦getsÂ¦ Â¦rea dyÂ¦ Â¦toÂ¦ Â¦ra iseÂ¦ Â¦upÂ¦ Â¦toÂ¦ â–â‚¬ Â¦8 00Â¦ Â¦billionÂ¦ Â¦underÂ¦  Â¦toÂ¦ Â¦f undÂ¦ Â¦theÂ¦ Â¦recoveryÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦takenÂ¦ Â¦stepsÂ¦ Â¦toÂ¦ Â¦ensureÂ¦ Â¦thatÂ¦ Â¦b orr owingÂ¦ Â¦underÂ¦ Â¦theÂ¦ Â¦temporaryÂ¦ Â¦recoveryÂ¦ Â¦inst ru mentÂ¦  Â¦willÂ¦ Â¦beÂ¦ Â¦fi na ncedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦mostÂ¦ Â¦adv an ta ge ousÂ¦ Â¦termsÂ¦ Â¦forÂ¦  Â¦countriesÂ¦ Â¦andÂ¦ Â¦theirÂ¦ Â¦citizensÂ¦ .
ğ‹‡ Â¦hu ma ni ta ri anÂ¦ Â¦aidÂ¦ Â¦workersÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦wa re ho useÂ¦ 
Â¦8Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2021Â¦ â–-â– ğ‹‡ Â¦teamÂ¦ ğ‹‡ Â¦europeÂ¦ Â¦contin uesÂ¦ Â¦toÂ¦ Â¦supportÂ¦ Â¦partnerÂ¦ Â¦countriesÂ¦ Â¦withÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ â–â‚¬ Â¦26Â¦ Â¦billionÂ¦ Â¦dis b ur sedÂ¦ Â¦inÂ¦ Â¦oneÂ¦ Â¦yearÂ¦
ğ‹‡Â¦byÂ¦ Â¦1Â¦ ğ‹‡ Â¦januaryÂ¦ Â¦2021Â¦ ,â– ğ‹‡ Â¦teamÂ¦ ğ‹‡ Â¦europeÂ¦ Â¦hadÂ¦ Â¦alreadyÂ¦ Â¦suppor tedÂ¦ Â¦overÂ¦ Â¦13 0Â¦ Â¦partnerÂ¦ Â¦countriesÂ¦ Â¦aroundÂ¦ Â¦theÂ¦ Â¦worldÂ¦ Â¦withÂ¦ Â¦overÂ¦ â–â‚¬ Â¦26Â¦ Â¦billionÂ¦ 
Â¦7Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2021Â¦ â–-â– ğ‹‡ Â¦globalÂ¦ ğ‹‡Â¦healthÂ¦ ğ‹‡ Â¦su mm itÂ¦ :â– ğ‹‡Â¦stayÂ¦ Â¦upÂ¦ Â¦toÂ¦ Â¦dateÂ¦ Â¦viaÂ¦ Â¦theÂ¦ Â¦newÂ¦ Â¦websiteÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦publishedÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦websiteÂ¦ Â¦withÂ¦ Â¦keyÂ¦ Â¦informationÂ¦ Â¦aboutÂ¦ Â¦theÂ¦ Â¦up co mingÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡Â¦healthÂ¦ ğ‹‡ Â¦su mm itÂ¦ .
ğ‹‡ Â¦imageÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦b er la y mon tÂ¦ Â¦ban nerÂ¦ â–" ğ‹‡ Â¦nextÂ¦ ğ‹‡ Â¦gener ationÂ¦  
Â¦6Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡Â¦firstÂ¦  -  Â¦supportÂ¦ Â¦measuresÂ¦ Â¦forÂ¦ Â¦recoveryÂ¦ Â¦andÂ¦ Â¦trans itionÂ¦ Â¦approvedÂ¦ Â¦forÂ¦ Â¦theÂ¦ ğ‹‡ Â¦netherlandsÂ¦ Â¦andÂ¦ ğ‹‡ Â¦au str iaÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦approvedÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦deci sionsÂ¦ Â¦underÂ¦  -  Â¦involvingÂ¦ Â¦mod if icationsÂ¦ Â¦ofÂ¦ Â¦fourÂ¦ Â¦oper a tionalÂ¦ Â¦programmesÂ¦ Â¦forÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦regionalÂ¦ ğ‹‡ Â¦developmentÂ¦ ğ‹‡Â¦f undÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡ Â¦netherlandsÂ¦ Â¦andÂ¦ ğ‹‡ Â¦au str iaÂ¦ Â¦thatÂ¦ Â¦willÂ¦ Â¦increaseÂ¦ Â¦theÂ¦ Â¦fundingÂ¦ Â¦availableÂ¦ Â¦forÂ¦ Â¦in ve st mentsÂ¦ Â¦byÂ¦ Â¦nearlyÂ¦ â–â‚¬ Â¦26 2Â¦ Â¦millionÂ¦ Â¦fromÂ¦  -  .
Â¦workerÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦sho pÂ¦ 
Â¦30Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦dis b ur sesÂ¦ Â¦furtherÂ¦ â–â‚¬ Â¦13Â¦ Â¦billionÂ¦ Â¦underÂ¦  Â¦toÂ¦ Â¦6Â¦ ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦toÂ¦ Â¦protectÂ¦ Â¦workersÂ¦ Â¦andÂ¦ Â¦jobsÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦dis b ur sedÂ¦ â–â‚¬ Â¦13Â¦ Â¦billionÂ¦ Â¦toÂ¦ Â¦sixÂ¦  ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦si x thÂ¦ Â¦inst al mentÂ¦ Â¦ofÂ¦ Â¦financialÂ¦ Â¦supportÂ¦ Â¦underÂ¦ Â¦theÂ¦  Â¦inst ru mentÂ¦ Â¦toÂ¦ Â¦protectÂ¦ Â¦jobsÂ¦ Â¦andÂ¦ Â¦workersÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦nurseÂ¦
Â¦26Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–â€“â– â‚¬ Â¦5Â¦ . Â¦1Â¦ Â¦billionÂ¦  Â¦ent ersÂ¦ Â¦intoÂ¦ Â¦forceÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦w el co medÂ¦ Â¦theÂ¦  Â¦programmeÂ¦ Â¦enteringÂ¦ Â¦intoÂ¦ Â¦forceÂ¦ .
ğ‹‡Â¦l otÂ¦ Â¦ofÂ¦ Â¦vaccinesÂ¦ Â¦dosesÂ¦ 
Â¦24Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–-â– ğ‹‡ Â¦commissionÂ¦ Â¦st re ng th ensÂ¦ Â¦trans pa re ncyÂ¦ Â¦andÂ¦ Â¦author isationÂ¦ Â¦mechan ismÂ¦ Â¦forÂ¦ Â¦exp ortsÂ¦ Â¦ofÂ¦ Â¦vaccinesÂ¦ Â¦againstÂ¦  - Â¦19Â¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦introducedÂ¦ Â¦additionalÂ¦ Â¦princ ip lesÂ¦ Â¦forÂ¦ Â¦consider ationÂ¦ Â¦beforeÂ¦ Â¦author isingÂ¦ Â¦exp ortsÂ¦ Â¦ofÂ¦ Â¦vaccinesÂ¦ :â– Â¦re ci pr oc ityÂ¦ Â¦andÂ¦ Â¦prop or tion alityÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦manÂ¦ Â¦sup erv isingÂ¦ Â¦aÂ¦ Â¦youngÂ¦ Â¦employerÂ¦ 
Â¦22Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡ Â¦reportÂ¦ Â¦conf ir msÂ¦  ' Â¦sÂ¦ Â¦success Â¦ Â¦inÂ¦ Â¦protectingÂ¦ Â¦jobsÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦publishedÂ¦ Â¦itsÂ¦ Â¦firstÂ¦ Â¦preliminaryÂ¦ Â¦assessmentÂ¦ Â¦ofÂ¦  ,â– Â¦theÂ¦ â–â‚¬ Â¦100Â¦ Â¦billionÂ¦ Â¦inst ru mentÂ¦ Â¦d ed ic atedÂ¦ Â¦toÂ¦ Â¦protectingÂ¦ Â¦jobsÂ¦ Â¦andÂ¦ Â¦ec onom iesÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦effectsÂ¦ Â¦ofÂ¦ Â¦theÂ¦  - Â¦19Â¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦g ir lÂ¦ Â¦waitingÂ¦ Â¦inÂ¦ Â¦lineÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦airp ortÂ¦ 
Â¦17Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦pro po sesÂ¦ Â¦aÂ¦ ğ‹‡ Â¦digitalÂ¦ ğ‹‡ Â¦gre enÂ¦ ğ‹‡ Â¦certificateÂ¦ Â¦withÂ¦ Â¦informationÂ¦ Â¦aboutÂ¦ Â¦vaccinationÂ¦ ,â– Â¦testsÂ¦ Â¦andÂ¦ Â¦recoveryÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦pro po sesÂ¦ Â¦toÂ¦ Â¦establishÂ¦ Â¦anÂ¦  - Â¦wideÂ¦ Â¦fra me workÂ¦ Â¦onÂ¦ Â¦aÂ¦ ğ‹‡ Â¦digitalÂ¦ ğ‹‡ Â¦gre enÂ¦ ğ‹‡ Â¦certificateÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦i ss u anceÂ¦ ,â– Â¦ver ificationÂ¦ Â¦andÂ¦ Â¦accep t anceÂ¦ Â¦ofÂ¦ Â¦vaccinationÂ¦ ,â– Â¦testingÂ¦ Â¦andÂ¦ Â¦recoveryÂ¦ Â¦cert ific atesÂ¦ .
ğ‹‡ Â¦twoÂ¦ Â¦peopleÂ¦ Â¦talkingÂ¦ 
Â¦16Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–-â– ğ‹‡ Â¦commissionÂ¦ Â¦dis b ur sesÂ¦ Â¦furtherÂ¦ â–â‚¬ Â¦9Â¦ Â¦billionÂ¦ Â¦underÂ¦  Â¦toÂ¦ Â¦7Â¦  ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦dis b ur sedÂ¦ â–â‚¬ Â¦9Â¦ Â¦billionÂ¦ Â¦toÂ¦ Â¦7Â¦  ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦fif thÂ¦ Â¦inst al mentÂ¦ Â¦underÂ¦ Â¦theÂ¦  Â¦inst ru mentÂ¦ .
Â¦vaccineÂ¦ Â¦vi alsÂ¦ 
Â¦11Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–-â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦author i sesÂ¦ Â¦f our thÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦gr an tedÂ¦ Â¦aÂ¦ Â¦con di tionalÂ¦ Â¦mar ke tingÂ¦ Â¦author isationÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦ Â¦developedÂ¦ Â¦byÂ¦ ğ‹‡ Â¦johnsonÂ¦ â–&â– ğ‹‡ Â¦johnsonÂ¦ ,â– Â¦makingÂ¦ Â¦itÂ¦ Â¦theÂ¦ Â¦f our thÂ¦ Â¦vaccineÂ¦ Â¦author isedÂ¦ Â¦inÂ¦ Â¦theÂ¦  .
ğ‹‡Â¦aÂ¦ Â¦nurseÂ¦ 
Â¦11Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦pro po sesÂ¦ Â¦toÂ¦ Â¦useÂ¦ â–â‚¬ Â¦53 0Â¦ Â¦millionÂ¦ Â¦underÂ¦ Â¦theÂ¦  ğ‹‡ Â¦solidarityÂ¦ Â¦f undÂ¦ Â¦toÂ¦ Â¦fightÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦isÂ¦ Â¦put tingÂ¦ Â¦for w ardÂ¦ Â¦aÂ¦ Â¦pack ageÂ¦ Â¦ofÂ¦ Â¦almostÂ¦ â–â‚¬ Â¦53 0Â¦ Â¦millionÂ¦ Â¦inÂ¦ Â¦financialÂ¦ Â¦supportÂ¦ Â¦underÂ¦ Â¦theÂ¦  ğ‹‡ Â¦solidarityÂ¦ ğ‹‡Â¦f undÂ¦ Â¦toÂ¦ Â¦supportÂ¦ Â¦publicÂ¦ Â¦exp end it ureÂ¦ Â¦onÂ¦ Â¦medicalÂ¦ Â¦andÂ¦ Â¦personalÂ¦ Â¦protectiveÂ¦ Â¦equipmentÂ¦ ,â– Â¦emergencyÂ¦ Â¦supportÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦populationÂ¦ ,â– Â¦andÂ¦ Â¦measuresÂ¦ Â¦toÂ¦ Â¦preventÂ¦ ,â– Â¦monitorÂ¦ Â¦andÂ¦ Â¦controlÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ .
ğ‹‡Â¦c arg oÂ¦ Â¦fre ightÂ¦ Â¦onÂ¦ Â¦p al et tesÂ¦ Â¦bra ndedÂ¦ Â¦withÂ¦  Â¦f la gÂ¦ Â¦beingÂ¦ Â¦ loa dedÂ¦ Â¦o nt oÂ¦ Â¦anÂ¦ Â¦airp la neÂ¦ 
Â¦10Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡ Â¦newÂ¦ Â¦actionÂ¦ Â¦forÂ¦  ' Â¦sÂ¦ Â¦globalÂ¦ Â¦aidÂ¦ Â¦deliveryÂ¦ Â¦challen gedÂ¦ Â¦byÂ¦  - Â¦19Â¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦presentedÂ¦ Â¦aÂ¦ ğ‹‡ Â¦commun icationÂ¦ Â¦onÂ¦ Â¦hu ma ni ta ri anÂ¦ Â¦actionÂ¦ ,â– Â¦s et tingÂ¦ Â¦outÂ¦ Â¦howÂ¦ Â¦theÂ¦  Â¦canÂ¦ Â¦stepÂ¦ Â¦upÂ¦ Â¦andÂ¦ Â¦meetÂ¦ Â¦hu ma ni ta ri anÂ¦ Â¦challen gesÂ¦ Â¦br oughtÂ¦ Â¦onÂ¦ Â¦byÂ¦ Â¦theÂ¦  - Â¦19Â¦ Â¦pandemicÂ¦ 
Â¦4Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡Â¦ ens uringÂ¦ Â¦aÂ¦ Â¦jo bÂ¦ - Â¦ri chÂ¦ Â¦recoveryÂ¦ :â– ğ‹‡ Â¦actionÂ¦ Â¦planÂ¦ Â¦onÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦ofÂ¦ ğ‹‡Â¦socialÂ¦ ğ‹‡ Â¦rightsÂ¦ Â¦s etsÂ¦ Â¦outÂ¦ Â¦effectiveÂ¦ Â¦supportÂ¦ Â¦toÂ¦ Â¦employ mentÂ¦
ğ‹‡Â¦asÂ¦ Â¦partÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦actionÂ¦ ğ‹‡ Â¦planÂ¦ Â¦onÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦pi ll arÂ¦ Â¦ofÂ¦ ğ‹‡Â¦socialÂ¦ ğ‹‡ Â¦rightsÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦presentedÂ¦ Â¦aÂ¦ ğ‹‡ Â¦recomm end ationÂ¦ Â¦forÂ¦ ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦toÂ¦ Â¦e aseÂ¦ Â¦theÂ¦ Â¦trans itionÂ¦ Â¦fromÂ¦ Â¦crisisÂ¦ - Â¦jo bÂ¦ - Â¦supportÂ¦ Â¦toÂ¦ Â¦cre atingÂ¦ Â¦futureÂ¦ - Â¦pr oo fÂ¦ Â¦jobsÂ¦ :â– ğ‹‡ Â¦effectiveÂ¦ ğ‹‡ Â¦activeÂ¦ ğ‹‡ Â¦supportÂ¦ Â¦toÂ¦ ğ‹‡ Â¦employ mentÂ¦ â–(  
Â¦3Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡Â¦oneÂ¦ Â¦yearÂ¦ Â¦sinceÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦ofÂ¦  - Â¦19Â¦ :â– Â¦updatedÂ¦ Â¦f is c alÂ¦ Â¦policyÂ¦ Â¦responseÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦adop tedÂ¦ Â¦aÂ¦ ğ‹‡ Â¦commun icationÂ¦ Â¦providingÂ¦ ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦withÂ¦ Â¦bro adÂ¦ Â¦guidanceÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦cond uc tÂ¦ Â¦ofÂ¦ Â¦f is c alÂ¦ Â¦policyÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦periodÂ¦ Â¦aheadÂ¦ Â¦andÂ¦ Â¦s et tingÂ¦ Â¦outÂ¦ Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ ' Â¦sÂ¦ Â¦consider ationsÂ¦ Â¦regardingÂ¦ Â¦theÂ¦ Â¦d ea ctiv ationÂ¦ Â¦orÂ¦ Â¦continuedÂ¦ Â¦activ ationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦generalÂ¦ Â¦ es c ap eÂ¦ Â¦cla useÂ¦ .
ğ‹‡Â¦presidentÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ 
Â¦24Â¦ ğ‹‡ Â¦februaryÂ¦ Â¦2021Â¦ â–-â– ğ‹‡Â¦presidentÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦spo keÂ¦ Â¦atÂ¦ Â¦theÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡Â¦c it iz enÂ¦ ğ‹‡ Â¦cam pa ignÂ¦ Â¦la un chÂ¦ Â¦eventÂ¦ â– â€˜ ğ‹‡Â¦aÂ¦ ğ‹‡ Â¦recoveryÂ¦ ğ‹‡ Â¦planÂ¦ Â¦forÂ¦ Â¦theÂ¦ ğ‹‡ Â¦worldÂ¦ '
ğ‹‡Â¦atÂ¦ Â¦theÂ¦ Â¦la un chÂ¦ Â¦evenÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡Â¦c it iz enÂ¦ ğ‹‡ Â¦cam pa ignÂ¦ ,â– ğ‹‡Â¦presidentÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦saidÂ¦ :â– ğ‹‡ Â¦letÂ¦ Â¦usÂ¦ Â¦over co meÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦globalÂ¦ Â¦vaccinationÂ¦ Â¦cam pa ignÂ¦ .
Â¦19Â¦ ğ‹‡ Â¦februaryÂ¦ Â¦2021Â¦ â–-â–  Â¦do ub lesÂ¦ Â¦contrib utionÂ¦ Â¦toÂ¦  Â¦toÂ¦ â–â‚¬ Â¦1Â¦ Â¦billionÂ¦ Â¦toÂ¦ Â¦ensureÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ Â¦vaccinesÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦unionÂ¦ Â¦announcedÂ¦ Â¦anÂ¦ Â¦additionalÂ¦ â–â‚¬ Â¦500Â¦ Â¦millionÂ¦ Â¦forÂ¦ Â¦theÂ¦  ğ‹‡ Â¦facilityÂ¦ ,â– Â¦do ub lingÂ¦ Â¦itsÂ¦ Â¦contrib utionÂ¦ Â¦toÂ¦ Â¦dateÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦globalÂ¦ Â¦initi ativeÂ¦ Â¦sec ureÂ¦ Â¦f airÂ¦ Â¦andÂ¦ Â¦e qu itableÂ¦ Â¦accessÂ¦ Â¦toÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦  - Â¦19Â¦ Â¦vaccinesÂ¦ .
Â¦17Â¦ ğ‹‡ Â¦februaryÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦t ac k lesÂ¦  - Â¦19Â¦ Â¦vari antsÂ¦ Â¦whileÂ¦ Â¦increasingÂ¦ Â¦preparednessÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦willÂ¦ Â¦establishÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦bi oÂ¦ - Â¦def enceÂ¦ Â¦planÂ¦ Â¦calledÂ¦  ğ‹‡ Â¦inc ub atorÂ¦ Â¦toÂ¦ Â¦t ac k leÂ¦ Â¦shortÂ¦ Â¦toÂ¦ Â¦medi umÂ¦ - Â¦termÂ¦ Â¦threat sÂ¦ Â¦andÂ¦ Â¦sim ul ta ne o uslyÂ¦ Â¦prepareÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦futureÂ¦ Â¦byÂ¦ Â¦ser vingÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦b lu e pr intÂ¦ Â¦forÂ¦ Â¦theÂ¦  â€™ Â¦sÂ¦ Â¦longÂ¦ Â¦termÂ¦ Â¦preparednessÂ¦ Â¦forÂ¦ Â¦healthÂ¦ Â¦emer ge nciesÂ¦ 
Â¦11Â¦ ğ‹‡ Â¦februaryÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡Â¦w in terÂ¦ Â¦2021Â¦ ğ‹‡ Â¦economicÂ¦ ğ‹‡ Â¦for ec astÂ¦ Â¦publishedÂ¦ :â– Â¦aÂ¦ Â¦challen gingÂ¦ Â¦w in terÂ¦ ,â– Â¦butÂ¦ Â¦lightÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦endÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦t un nelÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦publishedÂ¦ Â¦itsÂ¦ ğ‹‡Â¦w in terÂ¦ Â¦2021Â¦ ğ‹‡ Â¦economicÂ¦ ğ‹‡ Â¦for ec astÂ¦ ,â– Â¦whichÂ¦ Â¦proj ectsÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦e ur oÂ¦ Â¦areaÂ¦ Â¦economyÂ¦ Â¦willÂ¦ Â¦growÂ¦ Â¦byÂ¦ Â¦3Â¦ .
ğ‹‡ Â¦imageÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦b er la y mon tÂ¦ Â¦ban nerÂ¦ â–" ğ‹‡ Â¦nextÂ¦ ğ‹‡ Â¦gener ationÂ¦  
Â¦10Â¦ ğ‹‡ Â¦februaryÂ¦ Â¦2021Â¦ â–â€“â– â‚¬ Â¦6 7 2Â¦ . Â¦5Â¦ Â¦billionÂ¦ ğ‹‡ Â¦recoveryÂ¦ Â¦andÂ¦ ğ‹‡ Â¦re si li enceÂ¦ ğ‹‡ Â¦facilityÂ¦ Â¦toÂ¦ Â¦helpÂ¦ Â¦memberÂ¦ Â¦statesÂ¦ Â¦emer geÂ¦ Â¦stro ngerÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦crisisÂ¦ Â¦approvedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦parliamentÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦w el co mesÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦parliamentÂ¦ ' Â¦sÂ¦ Â¦v oteÂ¦ Â¦conf ir mingÂ¦ Â¦theÂ¦ Â¦politicalÂ¦ Â¦a gr ee mentÂ¦ Â¦reachedÂ¦ Â¦onÂ¦ Â¦theÂ¦ ğ‹‡ Â¦recoveryÂ¦ Â¦andÂ¦ ğ‹‡ Â¦re si li enceÂ¦ ğ‹‡ Â¦facilityÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦decemberÂ¦ Â¦2020Â¦ .
ğ‹‡Â¦a st ra ğ‹‡ z en ec aÂ¦ 
Â¦29Â¦ ğ‹‡ Â¦januaryÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦author i sesÂ¦ Â¦thirdÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦gr an tedÂ¦ Â¦aÂ¦ Â¦con di tionalÂ¦ Â¦mar ke tingÂ¦ Â¦author isationÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦ Â¦developedÂ¦ Â¦byÂ¦ ğ‹‡Â¦a st ra ğ‹‡ z en ec aÂ¦ ,â– Â¦makingÂ¦ Â¦itÂ¦ Â¦theÂ¦ Â¦thirdÂ¦ Â¦vaccineÂ¦ Â¦author isedÂ¦ Â¦inÂ¦ Â¦theÂ¦  .
Â¦pr oo fÂ¦ Â¦ofÂ¦  - Â¦19Â¦ Â¦vaccinationÂ¦ 
Â¦27Â¦ ğ‹‡ Â¦januaryÂ¦ Â¦2021Â¦ â–â€“â–  ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦adop tÂ¦ Â¦guidelinesÂ¦ Â¦onÂ¦ Â¦pr oo fÂ¦ Â¦ofÂ¦  - Â¦19Â¦ Â¦vaccinationÂ¦ Â¦forÂ¦ Â¦medicalÂ¦ Â¦pur po sesÂ¦
ğ‹‡Â¦theÂ¦  ğ‹‡ Â¦membersÂ¦ ğ‹‡ Â¦statesÂ¦ ,â– Â¦withÂ¦ Â¦theÂ¦ Â¦supportÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ ,â– Â¦adop tedÂ¦ Â¦guidelinesÂ¦ Â¦onÂ¦ Â¦pr oo fÂ¦ Â¦ofÂ¦  - Â¦19Â¦ Â¦vaccinationÂ¦ Â¦forÂ¦ Â¦medicalÂ¦ Â¦pur po sesÂ¦ .
ğ‹‡Â¦peopleÂ¦ Â¦w al kingÂ¦ Â¦inÂ¦ Â¦anÂ¦ Â¦airp ortÂ¦ 
Â¦25Â¦ ğ‹‡ Â¦januaryÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦pro po sesÂ¦ Â¦toÂ¦ Â¦updateÂ¦ Â¦theÂ¦ Â¦coordin atedÂ¦ Â¦approachÂ¦ Â¦onÂ¦ Â¦freeÂ¦ Â¦movementÂ¦ Â¦insideÂ¦ Â¦theÂ¦  ,â– Â¦andÂ¦ Â¦travelÂ¦ Â¦fromÂ¦ Â¦thirdÂ¦ Â¦countriesÂ¦ Â¦toÂ¦ Â¦theÂ¦ 
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦isÂ¦ Â¦prop os ingÂ¦ Â¦additionalÂ¦ Â¦sa fe gu ardsÂ¦ Â¦andÂ¦ Â¦require mentsÂ¦ Â¦forÂ¦ Â¦internationalÂ¦ Â¦travellersÂ¦ Â¦intoÂ¦ Â¦theÂ¦  ,â– Â¦andÂ¦ Â¦toÂ¦ Â¦updateÂ¦ Â¦theÂ¦ ğ‹‡ Â¦councilÂ¦ ğ‹‡ Â¦recomm end ationÂ¦ Â¦onÂ¦ Â¦coordin atedÂ¦ Â¦measuresÂ¦ Â¦affectingÂ¦ Â¦freeÂ¦ Â¦movementÂ¦ Â¦withinÂ¦ Â¦theÂ¦  .
Â¦vaccinesÂ¦ 
Â¦21Â¦ ğ‹‡ Â¦januaryÂ¦ Â¦2021Â¦ â–-â–  Â¦lea dersÂ¦ Â¦agreedÂ¦ Â¦onÂ¦ Â¦sp eedingÂ¦ Â¦upÂ¦ Â¦vaccinationÂ¦ Â¦andÂ¦ Â¦disc us sedÂ¦ Â¦otherÂ¦ Â¦measuresÂ¦ Â¦atÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦councilÂ¦
ğ‹‡Â¦atÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦councilÂ¦ Â¦meetingÂ¦ ,â– Â¦lea dersÂ¦ Â¦notedÂ¦ Â¦theÂ¦ Â¦serio us nessÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦situationÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦lightÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦newÂ¦ Â¦vari antsÂ¦ .
Â¦personÂ¦ Â¦beingÂ¦ Â¦vaccinatedÂ¦ 
Â¦19Â¦ ğ‹‡ Â¦januaryÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦s etsÂ¦ Â¦outÂ¦ Â¦keyÂ¦ Â¦actionsÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦unitedÂ¦ Â¦frontÂ¦ Â¦toÂ¦ Â¦b eatÂ¦  - Â¦19Â¦
ğ‹‡ Â¦twoÂ¦ Â¦daysÂ¦ Â¦aheadÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦lea dersÂ¦ â€™ â– Â¦v ide oc on fer enceÂ¦ Â¦onÂ¦ Â¦aÂ¦ Â¦coordin ateÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦setÂ¦ Â¦outÂ¦ Â¦actionsÂ¦ Â¦inÂ¦ Â¦aÂ¦ ğ‹‡ Â¦commun icationÂ¦ Â¦toÂ¦ Â¦stepÂ¦ Â¦upÂ¦ Â¦theÂ¦ Â¦fightÂ¦ Â¦againstÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ Â¦andÂ¦ Â¦sp e edÂ¦ Â¦upÂ¦ Â¦vaccinationÂ¦ .
Â¦g ir lÂ¦ Â¦gettingÂ¦ Â¦vaccinatedÂ¦ 
Â¦12Â¦ ğ‹‡ Â¦januaryÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦conclu desÂ¦ Â¦expl or atoryÂ¦ Â¦t al ksÂ¦ Â¦withÂ¦ ğ‹‡ Â¦val ne v aÂ¦ Â¦toÂ¦ Â¦sec ureÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦potentialÂ¦ Â¦vaccineÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦conclu dedÂ¦ Â¦expl or atoryÂ¦ Â¦t al ksÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦ph ar m ac eut icalÂ¦ Â¦com pa nyÂ¦ ğ‹‡ Â¦val ne v aÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦v iewÂ¦ Â¦toÂ¦ Â¦pur ch as ingÂ¦ Â¦itsÂ¦ Â¦potentialÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦ Â¦onceÂ¦ Â¦pr ov enÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ .
Â¦pfizerÂ¦ Â¦vaccineÂ¦ 
Â¦8Â¦ ğ‹‡ Â¦januaryÂ¦ Â¦2021Â¦ â–-â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦pro po sesÂ¦ Â¦toÂ¦ Â¦pur ch aseÂ¦ Â¦upÂ¦ Â¦toÂ¦ Â¦300Â¦ Â¦millionÂ¦ Â¦additionalÂ¦ Â¦dosesÂ¦ Â¦ofÂ¦  - ğ‹‡ Â¦pfizerÂ¦ Â¦vaccineÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦proposedÂ¦ Â¦toÂ¦  ğ‹‡ Â¦memberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦toÂ¦ Â¦pur ch aseÂ¦ Â¦anÂ¦ Â¦additionalÂ¦ Â¦200Â¦ Â¦millionÂ¦ Â¦dosesÂ¦ Â¦ofÂ¦ Â¦theÂ¦  Â¦andÂ¦ ğ‹‡ Â¦pfizerÂ¦  - Â¦19Â¦ Â¦vaccineÂ¦ ,â– Â¦withÂ¦ Â¦theÂ¦ Â¦optionÂ¦ Â¦ofÂ¦ Â¦ac qu i ringÂ¦ Â¦anotherÂ¦ Â¦100Â¦ Â¦millionÂ¦ Â¦dosesÂ¦ .
Â¦vaccinationÂ¦ Â¦medicalÂ¦ Â¦studentÂ¦ 
Â¦6Â¦ ğ‹‡ Â¦januaryÂ¦ Â¦2021Â¦ â–-â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦author i sesÂ¦ Â¦secondÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦commissionÂ¦ Â¦hasÂ¦ Â¦gr an tedÂ¦ Â¦aÂ¦ Â¦con di tionalÂ¦ Â¦mar ke tingÂ¦ Â¦author isationÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦ Â¦developedÂ¦ Â¦byÂ¦ ğ‹‡ Â¦modernaÂ¦ ,â– Â¦theÂ¦ Â¦secondÂ¦ Â¦vaccineÂ¦ Â¦author isedÂ¦ Â¦inÂ¦ Â¦theÂ¦  .
ğ‹‡ Â¦vaccinationÂ¦ Â¦prot ectsÂ¦ Â¦peopleÂ¦ Â¦againstÂ¦ Â¦seriousÂ¦ Â¦andÂ¦ Â¦lifeÂ¦ - Â¦threat eningÂ¦ Â¦infectiousÂ¦ Â¦diseasesÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦influenzaÂ¦ â–( Â¦fluÂ¦ ),â– Â¦di ph th eriaÂ¦ ,â– Â¦t et an usÂ¦ ,â– Â¦p ert us sisÂ¦ â–( Â¦who o pingÂ¦ Â¦coughÂ¦ ),â– Â¦measlesÂ¦ ,â– Â¦m um psÂ¦ ,â– Â¦ru be ll aÂ¦ â–( ğ‹‡Â¦g erm anÂ¦ Â¦measlesÂ¦ ),â– Â¦me ni ng oc oc c alÂ¦ Â¦diseaseÂ¦ ,â– Â¦inv asiveÂ¦ Â¦p ne um oc oc c alÂ¦ Â¦diseaseÂ¦ Â¦andÂ¦ Â¦po lioÂ¦ .
ğ‹‡ Â¦eachÂ¦ Â¦yearÂ¦ ,â– Â¦vaccinationÂ¦ Â¦sto psÂ¦ Â¦2Â¦ .
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ Â¦pastÂ¦ ,â– Â¦manyÂ¦ Â¦peopleÂ¦ Â¦diedÂ¦ Â¦ofÂ¦ Â¦diseasesÂ¦ Â¦thatÂ¦ Â¦canÂ¦ Â¦nowÂ¦ Â¦beÂ¦ Â¦pre v entedÂ¦ Â¦throughÂ¦ Â¦vaccinationÂ¦ .
ğ‹‡ Â¦measlesÂ¦
Â¦12Â¦ - Â¦18Â¦ Â¦peopleÂ¦ â–
ğ‹‡Â¦theÂ¦ Â¦centreÂ¦ Â¦d otÂ¦ Â¦re pr es entÂ¦ Â¦oneÂ¦ Â¦personÂ¦ Â¦affectedÂ¦ Â¦byÂ¦ Â¦aÂ¦ Â¦diseaseÂ¦ .
ğ‹‡ Â¦vaccinationÂ¦ Â¦helpsÂ¦ Â¦preventÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦diseaseÂ¦ Â¦inÂ¦ Â¦communitiesÂ¦ .
ğ‹‡Â¦t han ksÂ¦ Â¦toÂ¦ Â¦vaccinationÂ¦ :
Â¦s ma ll po xÂ¦ Â¦isÂ¦ Â¦nowÂ¦ Â¦e rad ic atedÂ¦ Â¦worldwideÂ¦ ;
Â¦transmissionÂ¦ Â¦ofÂ¦ Â¦po lioÂ¦ Â¦hasÂ¦ Â¦e ndedÂ¦ Â¦inÂ¦ Â¦mostÂ¦ Â¦partsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦worldÂ¦ ,â– Â¦includingÂ¦ ğ‹‡ Â¦europeÂ¦ .
ğ‹‡ Â¦vaccinationÂ¦ Â¦alsoÂ¦ Â¦pre v entsÂ¦ Â¦theÂ¦ Â¦developmentÂ¦ Â¦ofÂ¦ Â¦certainÂ¦ Â¦typesÂ¦ Â¦ofÂ¦ Â¦preÂ¦ - Â¦cance r ousÂ¦ Â¦gr ow thsÂ¦ Â¦andÂ¦ Â¦ca nc ersÂ¦ ,â– Â¦forÂ¦ Â¦exampleÂ¦ :
Â¦v accin atingÂ¦ Â¦againstÂ¦ Â¦hum an p ap illo maÂ¦ Â¦virusÂ¦ â–(  )â– Â¦canÂ¦ Â¦helpÂ¦ Â¦preventÂ¦ Â¦c erv icalÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦ca nc ersÂ¦ Â¦causedÂ¦ Â¦byÂ¦  Â¦infectionÂ¦ ;
Â¦v accin atingÂ¦ Â¦againstÂ¦ Â¦he p at itisÂ¦ ğ‹‡Â¦bÂ¦ Â¦canÂ¦ Â¦helpÂ¦ Â¦preventÂ¦ Â¦liverÂ¦ Â¦cancerÂ¦ Â¦causedÂ¦ Â¦byÂ¦ Â¦longÂ¦ - Â¦termÂ¦ Â¦he p at itisÂ¦ ğ‹‡Â¦bÂ¦ Â¦infectionÂ¦ .
ğ‹‡ Â¦vaccinationÂ¦ Â¦programmesÂ¦ Â¦haveÂ¦ Â¦wi derÂ¦ Â¦soci etalÂ¦ Â¦benef itsÂ¦ .
ğ‹‡ Â¦vaccinationÂ¦ Â¦isÂ¦ Â¦theÂ¦ Â¦bestÂ¦ Â¦wayÂ¦ Â¦toÂ¦ Â¦ac qu ireÂ¦ Â¦immunityÂ¦ Â¦againstÂ¦ Â¦vaccineÂ¦ - Â¦pre vent ableÂ¦ Â¦diseasesÂ¦ ,â– Â¦asÂ¦ Â¦o pp osedÂ¦ Â¦toÂ¦ Â¦immunityÂ¦ Â¦at tainedÂ¦ Â¦byÂ¦ Â¦gettingÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ .
ğ‹‡ Â¦vaccinationÂ¦ Â¦prot ectsÂ¦ Â¦theÂ¦ Â¦vaccinatedÂ¦ Â¦personsÂ¦ Â¦andÂ¦ Â¦thoseÂ¦ Â¦aroundÂ¦ Â¦themÂ¦ Â¦whoÂ¦ Â¦areÂ¦ Â¦vulnerableÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦diseasesÂ¦ ,â– Â¦reducingÂ¦ Â¦theÂ¦ Â¦riskÂ¦ Â¦ofÂ¦ Â¦diseasesÂ¦ Â¦spreadingÂ¦ Â¦amongÂ¦ Â¦familyÂ¦ Â¦membersÂ¦ ,â– Â¦schoolÂ¦ Â¦m atesÂ¦ Â¦orÂ¦ Â¦colleaguesÂ¦ ,â– Â¦friendsÂ¦ ,â– Â¦ne igh b oursÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦peopleÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦communityÂ¦ .
ğ‹‡Â¦whenÂ¦ Â¦enoughÂ¦ Â¦peopleÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦populationÂ¦ Â¦areÂ¦ Â¦immuneÂ¦ Â¦toÂ¦ Â¦anÂ¦ Â¦infectiousÂ¦ Â¦diseaseÂ¦ ,â– Â¦theÂ¦ Â¦diseaseÂ¦ Â¦isÂ¦ Â¦thenÂ¦ Â¦unli k elyÂ¦ Â¦toÂ¦ Â¦spreadÂ¦ Â¦fromÂ¦ Â¦personÂ¦ Â¦toÂ¦ Â¦personÂ¦ .
ğ‹‡Â¦communityÂ¦ Â¦immunityÂ¦
ğ‹‡Â¦communityÂ¦ Â¦immunityÂ¦ Â¦occursÂ¦ Â¦whenÂ¦ Â¦enoughÂ¦ Â¦peopleÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦populationÂ¦ Â¦areÂ¦ Â¦immuneÂ¦ Â¦toÂ¦ Â¦anÂ¦ Â¦infectiousÂ¦ Â¦diseaseÂ¦
ğ‹‡Â¦inÂ¦ Â¦thisÂ¦ Â¦wayÂ¦ ,â– Â¦vaccinesÂ¦ Â¦indir ectlyÂ¦ Â¦protectÂ¦ Â¦othersÂ¦ Â¦whoÂ¦ Â¦areÂ¦ Â¦vulnerableÂ¦ Â¦toÂ¦ Â¦diseaseÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦meansÂ¦ Â¦thatÂ¦ Â¦peopleÂ¦ Â¦whoÂ¦ Â¦cannotÂ¦ Â¦beÂ¦ Â¦vaccinatedÂ¦ ,â– Â¦forÂ¦ Â¦instanceÂ¦ Â¦becauseÂ¦ Â¦theyÂ¦ Â¦areÂ¦ Â¦tooÂ¦ Â¦youngÂ¦ Â¦orÂ¦ Â¦all er g icÂ¦ Â¦toÂ¦ Â¦vaccineÂ¦ Â¦componentsÂ¦ ,â– Â¦benef itÂ¦ Â¦fromÂ¦ Â¦othersÂ¦ Â¦beingÂ¦ Â¦vaccinatedÂ¦ ,â– Â¦becauseÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ Â¦cannotÂ¦ Â¦easi lyÂ¦ Â¦spreadÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦communityÂ¦ .
ğ‹‡Â¦forÂ¦ Â¦exampleÂ¦ ,â– Â¦toÂ¦ Â¦ensureÂ¦ Â¦communityÂ¦ Â¦immunityÂ¦ Â¦againstÂ¦ Â¦measlesÂ¦ ,â– Â¦publicÂ¦ Â¦healthÂ¦ Â¦authoritiesÂ¦ Â¦recommendÂ¦ Â¦thatÂ¦ Â¦95Â¦ %â– Â¦ofÂ¦ Â¦theÂ¦ Â¦populationÂ¦ Â¦areÂ¦ Â¦vaccinatedÂ¦ Â¦withÂ¦ Â¦twoÂ¦ Â¦dosesÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦ Â¦measlesÂ¦ â–( Â¦theÂ¦  Â¦vaccineÂ¦ ,â– Â¦whichÂ¦ Â¦prot ectsÂ¦ Â¦againstÂ¦ Â¦measlesÂ¦ ,â– Â¦m um psÂ¦ Â¦andÂ¦ Â¦ru be ll aÂ¦ ).
ğ‹‡Â¦howeverÂ¦ ,â– Â¦peopleÂ¦ Â¦cannotÂ¦ Â¦r elyÂ¦ Â¦onÂ¦ Â¦communityÂ¦ Â¦immunityÂ¦ Â¦forÂ¦ Â¦someÂ¦ Â¦infectiousÂ¦ Â¦diseasesÂ¦ .
ğ‹‡Â¦f ur th erm oreÂ¦ ,â– Â¦immun isationÂ¦ Â¦programmesÂ¦ Â¦helpÂ¦ Â¦reduceÂ¦ Â¦theÂ¦ Â¦socialÂ¦ ,â– Â¦psych ologicalÂ¦ Â¦andÂ¦ Â¦financialÂ¦ Â¦bur d ensÂ¦ Â¦ofÂ¦ Â¦diseaseÂ¦ Â¦onÂ¦ Â¦peopleÂ¦ Â¦andÂ¦ Â¦governmentsÂ¦ ,â– Â¦reducingÂ¦ Â¦p ress uresÂ¦ Â¦onÂ¦ Â¦healthcareÂ¦ Â¦andÂ¦ Â¦socialÂ¦ Â¦careÂ¦ Â¦systemsÂ¦ Â¦andÂ¦ Â¦en ab lingÂ¦ Â¦peopleÂ¦ Â¦toÂ¦ Â¦pu rs ueÂ¦ Â¦produc tiveÂ¦ Â¦activitiesÂ¦ Â¦includingÂ¦ Â¦educationÂ¦ Â¦andÂ¦ Â¦employ mentÂ¦ .
ğ‹‡ Â¦vaccinationÂ¦ Â¦prot ectsÂ¦ Â¦individualsÂ¦ Â¦againstÂ¦ Â¦diseasesÂ¦ Â¦thatÂ¦ Â¦couldÂ¦ Â¦haveÂ¦ Â¦seriousÂ¦ Â¦conse qu encesÂ¦ Â¦forÂ¦ Â¦theirÂ¦ Â¦healthÂ¦ ,â– Â¦forÂ¦ Â¦exampleÂ¦ :
Â¦di ph th eriaÂ¦ Â¦ki llsÂ¦ Â¦1Â¦ Â¦inÂ¦ Â¦everyÂ¦ Â¦10Â¦ Â¦peopleÂ¦ Â¦whoÂ¦ Â¦getÂ¦ Â¦itÂ¦ ,â– Â¦evenÂ¦ Â¦withÂ¦ Â¦treatmentÂ¦ â–( Â¦1Â¦ ) ;
Â¦almostÂ¦ Â¦9Â¦ Â¦outÂ¦ Â¦ofÂ¦ Â¦10Â¦ Â¦b ab iesÂ¦ Â¦bor nÂ¦ Â¦toÂ¦ Â¦mo th ersÂ¦ Â¦whoÂ¦ Â¦hadÂ¦ Â¦ru be ll aÂ¦ Â¦inÂ¦ Â¦earlyÂ¦ Â¦pregnancyÂ¦ ,â– Â¦willÂ¦ Â¦suff erÂ¦ Â¦fromÂ¦ Â¦co ng en italÂ¦ Â¦ru be ll aÂ¦ Â¦syndromeÂ¦ â–( Â¦withÂ¦ Â¦conditionsÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦d ea f nessÂ¦ ,â– Â¦cat ar ac tsÂ¦ Â¦andÂ¦ Â¦learningÂ¦ Â¦disabilitiesÂ¦ ) â–( Â¦2Â¦ ) ;
Â¦me ni ng oc oc c alÂ¦ Â¦diseaseÂ¦ Â¦ki llsÂ¦ Â¦1Â¦ Â¦inÂ¦ Â¦10Â¦ Â¦peopleÂ¦ Â¦affectedÂ¦ ,â– Â¦evenÂ¦ Â¦withÂ¦ Â¦pro mp tÂ¦ Â¦diagnosisÂ¦ Â¦andÂ¦ Â¦treatmentÂ¦ ,â– Â¦whileÂ¦ Â¦problemsÂ¦ Â¦includingÂ¦ Â¦ne ur ologicalÂ¦ Â¦orÂ¦ Â¦hea ringÂ¦ Â¦imp a ir mentÂ¦ Â¦andÂ¦ Â¦a mp u tationÂ¦ Â¦occurÂ¦ Â¦inÂ¦ Â¦upÂ¦ Â¦toÂ¦ Â¦20Â¦ %â– Â¦ofÂ¦ Â¦surv iv orsÂ¦ â–( Â¦3Â¦ );â–
Â¦measlesÂ¦ Â¦isÂ¦ Â¦highlyÂ¦ Â¦contagiousÂ¦ Â¦andÂ¦ Â¦3Â¦ Â¦outÂ¦ Â¦ofÂ¦ Â¦10Â¦ Â¦peopleÂ¦ Â¦affectedÂ¦ Â¦developÂ¦ Â¦complicationsÂ¦ â–( Â¦4Â¦ ),â– Â¦whichÂ¦ Â¦canÂ¦ Â¦includeÂ¦ Â¦ earÂ¦ Â¦infectionÂ¦ ,â– Â¦diar rho e aÂ¦ ,â– Â¦pneumoniaÂ¦ Â¦andÂ¦ Â¦en ce ph al itisÂ¦ â–( Â¦infla m mationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦bra inÂ¦ Â¦tissueÂ¦ ) ;
Â¦p ert us sisÂ¦ â–( Â¦who o pingÂ¦ Â¦coughÂ¦ )â– Â¦canÂ¦ Â¦beÂ¦ Â¦particularlyÂ¦ Â¦seriousÂ¦ Â¦inÂ¦ Â¦infantsÂ¦ ,â– Â¦causingÂ¦ Â¦coughingÂ¦ Â¦sp e llsÂ¦ Â¦thatÂ¦ Â¦mayÂ¦ Â¦re cu rÂ¦ Â¦forÂ¦ Â¦upÂ¦ Â¦toÂ¦ Â¦twoÂ¦ Â¦monthsÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦listÂ¦ Â¦withÂ¦ Â¦exa mp lesÂ¦ Â¦includesÂ¦ Â¦diseasesÂ¦ Â¦forÂ¦ Â¦whichÂ¦ Â¦vaccinesÂ¦ Â¦areÂ¦ Â¦includedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦nationalÂ¦ Â¦immun isationÂ¦ Â¦programmesÂ¦ ,â– Â¦andÂ¦ / Â¦orÂ¦ Â¦areÂ¦ Â¦givenÂ¦ Â¦toÂ¦ Â¦personsÂ¦ Â¦consideredÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦atÂ¦ Â¦aÂ¦ Â¦higherÂ¦ Â¦riskÂ¦ Â¦ofÂ¦ Â¦gettingÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ .
ğ‹‡Â¦vaccinesÂ¦ Â¦protectÂ¦ Â¦peopleÂ¦ Â¦duringÂ¦ Â¦differentÂ¦ Â¦stagesÂ¦ Â¦ofÂ¦ Â¦lifeÂ¦ .
ğ‹‡Â¦nationalÂ¦ Â¦vaccinationÂ¦ Â¦schedu lesÂ¦ Â¦inÂ¦  /  Â¦countriesÂ¦ Â¦recommendÂ¦ Â¦vaccinesÂ¦ Â¦atÂ¦ Â¦specificÂ¦ Â¦ agesÂ¦ Â¦andÂ¦ Â¦forÂ¦ Â¦specificÂ¦ Â¦pop ulationsÂ¦ .
ğ‹‡ Â¦healthcareÂ¦ Â¦prof es sion alsÂ¦
ğ‹‡Â¦someÂ¦ Â¦vaccinesÂ¦ Â¦areÂ¦ Â¦notÂ¦ Â¦partÂ¦ Â¦ofÂ¦ Â¦routineÂ¦ Â¦vaccinationÂ¦ Â¦schedu lesÂ¦ Â¦butÂ¦ Â¦areÂ¦ Â¦targe tedÂ¦ Â¦atÂ¦ Â¦specificÂ¦ Â¦groupsÂ¦ .
ğ‹‡ Â¦eachÂ¦  /  Â¦countryÂ¦ Â¦isÂ¦ Â¦respon sibleÂ¦ Â¦forÂ¦ Â¦itsÂ¦ Â¦ownÂ¦ Â¦nationalÂ¦ Â¦publicÂ¦ Â¦healthÂ¦ Â¦policyÂ¦ ,â– Â¦includingÂ¦ Â¦itsÂ¦ Â¦nationalÂ¦ Â¦immun isationÂ¦ Â¦programmeÂ¦ Â¦andÂ¦ Â¦vaccinationÂ¦ Â¦scheduleÂ¦ .â– ğ‹‡ Â¦informationÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦nationalÂ¦ Â¦vaccinationÂ¦ Â¦schedu lesÂ¦ Â¦inÂ¦  /  Â¦countriesÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦foundÂ¦ Â¦inÂ¦ Â¦theÂ¦  ğ‹‡ Â¦vaccineÂ¦ ğ‹‡ Â¦schedu l erÂ¦
ğ‹‡Â¦thereÂ¦ Â¦areÂ¦ Â¦someÂ¦ Â¦diff er encesÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦wayÂ¦ Â¦countriesÂ¦ Â¦organ iseÂ¦ Â¦theirÂ¦ Â¦vaccinationÂ¦ Â¦schedu lesÂ¦ ,â– Â¦whichÂ¦ Â¦areÂ¦ Â¦similarÂ¦ Â¦butÂ¦ Â¦notÂ¦ Â¦identicalÂ¦ Â¦inÂ¦ Â¦differentÂ¦  /  Â¦countriesÂ¦ .
ğ‹‡ Â¦factorsÂ¦ Â¦dr ivingÂ¦ Â¦suchÂ¦ Â¦diff er encesÂ¦ Â¦mayÂ¦ Â¦includeÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ ' Â¦sÂ¦ Â¦bur denÂ¦ ,â– Â¦prevalenceÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ Â¦andÂ¦ Â¦trendsÂ¦ Â¦inÂ¦ Â¦differentÂ¦ Â¦countriesÂ¦ ,â– Â¦theÂ¦ Â¦resourcesÂ¦ Â¦andÂ¦ Â¦st ru ct uresÂ¦ Â¦ofÂ¦ Â¦healthcareÂ¦ Â¦systemsÂ¦ ,â– Â¦politicalÂ¦ Â¦andÂ¦ Â¦culturalÂ¦ Â¦factorsÂ¦ ,â– Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦re si li enceÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦vaccinationÂ¦ Â¦programmeÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦diff er encesÂ¦ Â¦betweenÂ¦ Â¦vaccinationÂ¦ Â¦schedu lesÂ¦ Â¦doÂ¦ Â¦notÂ¦ Â¦me anÂ¦ Â¦thatÂ¦ Â¦someÂ¦ Â¦areÂ¦ Â¦betterÂ¦ Â¦thanÂ¦ Â¦othersÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦ch ild h oodÂ¦ Â¦vaccinationÂ¦ Â¦schedu lesÂ¦ Â¦inÂ¦ Â¦allÂ¦  /  Â¦countriesÂ¦ Â¦includeÂ¦ Â¦theÂ¦ Â¦vaccinationÂ¦ Â¦againstÂ¦ :
Â¦measlesÂ¦
Â¦m um psÂ¦
Â¦ru be ll aÂ¦
Â¦di ph th eriaÂ¦
Â¦t et an usÂ¦
Â¦p ert us sisÂ¦ â–( Â¦who o pingÂ¦ Â¦coughÂ¦ )
Â¦po li om y el itisÂ¦
ğ‹‡ Â¦ha e mo ph il usÂ¦ Â¦influ en z a eÂ¦ Â¦typeÂ¦ ğ‹‡Â¦bÂ¦
Â¦humanÂ¦ Â¦p ap illo ma virusÂ¦ â–( Â¦ad ol es centÂ¦ / Â¦preÂ¦ - Â¦ad ol es centÂ¦ Â¦g ir l sÂ¦ ).
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦worldÂ¦ ğ‹‡Â¦healthÂ¦ ğ‹‡ Â¦organizationÂ¦ â–(  )â– Â¦recommendsÂ¦ Â¦vaccinationÂ¦ Â¦againstÂ¦ Â¦he p at itisÂ¦ ğ‹‡Â¦bÂ¦ Â¦asÂ¦ Â¦partÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦uni vers alÂ¦ Â¦ch ild h oodÂ¦ Â¦vaccinationÂ¦ Â¦scheduleÂ¦ ,â– Â¦butÂ¦ Â¦someÂ¦  /  Â¦countriesÂ¦ Â¦onlyÂ¦ Â¦v accin ateÂ¦ Â¦childrenÂ¦ Â¦atÂ¦ Â¦highÂ¦ Â¦riskÂ¦ Â¦ofÂ¦ Â¦infectionÂ¦ Â¦andÂ¦ Â¦adultsÂ¦ Â¦inÂ¦ Â¦keyÂ¦ Â¦riskÂ¦ Â¦groupsÂ¦ .
ğ‹‡Â¦childrenÂ¦ Â¦inÂ¦ Â¦someÂ¦  /  Â¦countriesÂ¦ Â¦areÂ¦ Â¦offeredÂ¦ Â¦protectionÂ¦ Â¦throughÂ¦ Â¦vaccinationÂ¦ Â¦againstÂ¦ :
Â¦he p at itisÂ¦ ğ‹‡Â¦aÂ¦
Â¦influenzaÂ¦
Â¦inv asiveÂ¦ Â¦diseaseÂ¦ Â¦causedÂ¦ Â¦byÂ¦ ğ‹‡Â¦ne i ss eriaÂ¦ Â¦m en in gi ti di sÂ¦
Â¦inv asiveÂ¦ Â¦diseaseÂ¦ Â¦causedÂ¦ Â¦byÂ¦ ğ‹‡Â¦st re pt oc oc c usÂ¦ Â¦p ne u mon ia eÂ¦
Â¦ro ta virusÂ¦
Â¦t ub er cu lo sisÂ¦
Â¦vari ce ll aÂ¦
ğ‹‡Â¦inÂ¦ Â¦additionÂ¦ ,â– Â¦allÂ¦  /  Â¦countriesÂ¦ Â¦haveÂ¦ Â¦recommendationsÂ¦ Â¦forÂ¦ Â¦seasonalÂ¦ Â¦influenzaÂ¦ â–( Â¦fluÂ¦ )â– Â¦forÂ¦ Â¦olderÂ¦ Â¦peopleÂ¦ Â¦andÂ¦ Â¦keyÂ¦ Â¦riskÂ¦ Â¦groupsÂ¦ .
ğ‹‡Â¦theÂ¦  Â¦isÂ¦ Â¦exp lo ringÂ¦ Â¦furtherÂ¦ Â¦har mon isationÂ¦ Â¦ofÂ¦ Â¦nationalÂ¦ Â¦vaccinationÂ¦ Â¦schedu lesÂ¦ .â– ğ‹‡Â¦theÂ¦  ğ‹‡ Â¦councilÂ¦ Â¦issuedÂ¦ ğ‹‡ Â¦recommendationsÂ¦ Â¦onÂ¦ Â¦7Â¦ ğ‹‡ Â¦decemberÂ¦ Â¦20 18Â¦
Â¦onÂ¦ Â¦st re ng th enedÂ¦ Â¦co op er ationÂ¦ Â¦againstÂ¦ Â¦vaccineÂ¦ - Â¦pre vent ableÂ¦ Â¦diseasesÂ¦ ,â– Â¦whichÂ¦ Â¦includeÂ¦ Â¦exa mi ningÂ¦ Â¦theÂ¦ Â¦f ea si bilityÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦c oreÂ¦  Â¦vaccinationÂ¦ Â¦scheduleÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦ai mÂ¦ Â¦wouldÂ¦ Â¦beÂ¦ Â¦toÂ¦ Â¦improveÂ¦ Â¦theÂ¦ Â¦com pa ti bilityÂ¦ Â¦ofÂ¦ Â¦nationalÂ¦ Â¦vaccinationÂ¦ Â¦schedu lesÂ¦ Â¦andÂ¦ Â¦pr om oteÂ¦ Â¦e q ualÂ¦ Â¦accessÂ¦ Â¦toÂ¦ Â¦vaccinationsÂ¦ Â¦acrossÂ¦ Â¦theÂ¦  .
ğ‹‡ Â¦eachÂ¦  /  Â¦countryÂ¦ Â¦implement sÂ¦ Â¦itsÂ¦ Â¦ownÂ¦ Â¦immun isationÂ¦ Â¦programmeÂ¦ .
 /  Â¦countriesÂ¦ Â¦haveÂ¦ Â¦ach ie vedÂ¦ Â¦highÂ¦ Â¦vaccinationÂ¦ Â¦coverageÂ¦ Â¦ratesÂ¦ Â¦throughÂ¦ Â¦mandatoryÂ¦ Â¦andÂ¦ Â¦nonÂ¦ - Â¦mandatoryÂ¦ Â¦vaccinationÂ¦ .
ğ‹‡ Â¦eachÂ¦  /  Â¦countryÂ¦ Â¦deci desÂ¦ Â¦ifÂ¦ Â¦vaccinationÂ¦ Â¦isÂ¦ Â¦mandatoryÂ¦ Â¦orÂ¦ Â¦volu nt aryÂ¦ Â¦inÂ¦ Â¦itsÂ¦ Â¦t err it oryÂ¦ .
ğ‹‡ Â¦informationÂ¦ Â¦onÂ¦ Â¦whichÂ¦ Â¦countriesÂ¦ Â¦haveÂ¦ Â¦mandatoryÂ¦ Â¦vaccinationÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦foundÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡ Â¦vaccineÂ¦ ğ‹‡ Â¦schedu l erÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦peopleÂ¦ Â¦mayÂ¦ Â¦haveÂ¦ Â¦mis sedÂ¦ Â¦aÂ¦ Â¦vaccinationÂ¦ Â¦orÂ¦ Â¦didÂ¦ Â¦notÂ¦ Â¦getÂ¦ Â¦theÂ¦ Â¦recommendedÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦dosesÂ¦ .
ğ‹‡Â¦everyoneÂ¦ Â¦shouldÂ¦ Â¦checkÂ¦ Â¦ifÂ¦ Â¦theyÂ¦ Â¦haveÂ¦ Â¦hadÂ¦ Â¦theÂ¦ Â¦nationallyÂ¦ Â¦recommendedÂ¦ Â¦vaccinationsÂ¦ ,â– Â¦andÂ¦ Â¦cons ul tÂ¦ Â¦aÂ¦ Â¦medicalÂ¦ Â¦professionalÂ¦ Â¦inÂ¦ Â¦caseÂ¦ Â¦anyÂ¦ Â¦catchÂ¦ - Â¦u psÂ¦ Â¦areÂ¦ Â¦neededÂ¦ .
ğ‹‡Â¦ifÂ¦ Â¦aÂ¦ Â¦personÂ¦ Â¦doesÂ¦ Â¦notÂ¦ Â¦knowÂ¦ Â¦ifÂ¦ Â¦theyÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦vaccinatedÂ¦ Â¦againstÂ¦ Â¦aÂ¦ Â¦certainÂ¦ Â¦diseaseÂ¦ Â¦theyÂ¦ Â¦canÂ¦ Â¦usuallyÂ¦ Â¦getÂ¦ Â¦anÂ¦ Â¦extraÂ¦ Â¦doseÂ¦ Â¦withoutÂ¦ Â¦increasingÂ¦ Â¦theÂ¦ Â¦riskÂ¦ Â¦ofÂ¦ Â¦seriousÂ¦ Â¦sideÂ¦ Â¦effectsÂ¦ â–( Â¦1Â¦ ).
Â¦measlesÂ¦ Â¦vaccineÂ¦
 Â¦i ğ‹‡ st ockÂ¦
ğ‹‡ Â¦catchÂ¦ - Â¦upÂ¦ Â¦vaccinationÂ¦ Â¦programmesÂ¦ Â¦forÂ¦ Â¦specificÂ¦ Â¦diseasesÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦organ isedÂ¦ .
ğ‹‡Â¦mostÂ¦ Â¦vaccinesÂ¦ Â¦provideÂ¦ Â¦li fe lo ngÂ¦ Â¦immunityÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦someÂ¦ Â¦vaccinesÂ¦ Â¦provideÂ¦ Â¦immunityÂ¦ Â¦thatÂ¦ Â¦dec rea sesÂ¦ Â¦overÂ¦ Â¦timeÂ¦ ,â– Â¦knownÂ¦ Â¦asÂ¦ â– â€˜ Â¦wa ningÂ¦ Â¦immunityÂ¦ â€™ .â– ğ‹‡Â¦someÂ¦ Â¦countriesÂ¦ Â¦recommendÂ¦ Â¦bo os terÂ¦ Â¦dosesÂ¦ Â¦atÂ¦ Â¦regularÂ¦ Â¦interv alsÂ¦ Â¦duringÂ¦ Â¦ad ol es c enceÂ¦ Â¦andÂ¦ Â¦ad ul th oodÂ¦ ,â– Â¦inÂ¦ Â¦orderÂ¦ Â¦toÂ¦ Â¦maintainÂ¦ Â¦immunityÂ¦ Â¦overÂ¦ Â¦aÂ¦ Â¦longerÂ¦ Â¦periodÂ¦ Â¦ofÂ¦ Â¦timeÂ¦ ,â– Â¦againstÂ¦ Â¦forÂ¦ Â¦exampleÂ¦ :
Â¦di ph th eriaÂ¦
Â¦t et an usÂ¦
Â¦p ert us sisÂ¦ â–( Â¦who o pingÂ¦ Â¦coughÂ¦ )
ğ‹‡Â¦someÂ¦ Â¦countriesÂ¦ Â¦recommendÂ¦ Â¦b oo st ersÂ¦ Â¦specificallyÂ¦ Â¦forÂ¦ Â¦individualsÂ¦ Â¦travellingÂ¦ Â¦orÂ¦ Â¦atÂ¦ Â¦increasedÂ¦ Â¦riskÂ¦ Â¦ofÂ¦ Â¦beingÂ¦ Â¦exposedÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ .â–
ğ‹‡ Â¦healthcareÂ¦ Â¦providersÂ¦ Â¦canÂ¦ Â¦provideÂ¦ Â¦informationÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦bo os terÂ¦ Â¦dosesÂ¦ Â¦neededÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦vaccineÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦contr ai nd ic atedÂ¦ Â¦forÂ¦ Â¦certainÂ¦ Â¦peopleÂ¦ ,â– Â¦mea ningÂ¦ Â¦theyÂ¦ Â¦shouldÂ¦ Â¦notÂ¦ Â¦receiveÂ¦ Â¦itÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦vaccineÂ¦ Â¦isÂ¦ Â¦contr ai nd ic atedÂ¦ Â¦toÂ¦ Â¦thoseÂ¦ Â¦all er g icÂ¦ Â¦toÂ¦ Â¦anyÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦activeÂ¦ Â¦subst ancesÂ¦ Â¦orÂ¦ Â¦ingredi entsÂ¦ Â¦asÂ¦ Â¦l is tedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦produc tÂ¦ Â¦informationÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦historyÂ¦ Â¦ofÂ¦ â–' Â¦an ap hy la ct icÂ¦ 'â– Â¦orÂ¦ Â¦otherÂ¦ Â¦seriousÂ¦ Â¦all er g icÂ¦ Â¦reactionÂ¦ Â¦afterÂ¦ Â¦receivingÂ¦ Â¦aÂ¦ Â¦vaccineÂ¦ Â¦isÂ¦ Â¦aÂ¦ Â¦contr ai nd icationÂ¦ Â¦toÂ¦ Â¦furtherÂ¦ Â¦dosesÂ¦ Â¦ofÂ¦ Â¦thatÂ¦ Â¦vaccineÂ¦ .
ğ‹‡ Â¦certainÂ¦ Â¦immuneÂ¦ Â¦systemÂ¦ Â¦disor dersÂ¦ â–( Â¦eÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦someÂ¦ Â¦casesÂ¦ ,â– Â¦theÂ¦ Â¦comple tionÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦immun is ationsÂ¦ Â¦neededÂ¦ Â¦isÂ¦ Â¦recommendedÂ¦ Â¦priorÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦startÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦treatmentÂ¦ ,â– Â¦asÂ¦ Â¦duringÂ¦ Â¦theÂ¦ Â¦treatmentÂ¦ Â¦theÂ¦ Â¦patientÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦atÂ¦ Â¦higherÂ¦ Â¦ris ksÂ¦ Â¦ofÂ¦ Â¦infectionÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦vaccinesÂ¦ Â¦areÂ¦ Â¦contr ai nd ic atedÂ¦ Â¦duringÂ¦ Â¦pregnancyÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦measlesÂ¦ ,â– Â¦m um psÂ¦ Â¦andÂ¦ Â¦ru be ll aÂ¦ .
ğ‹‡Â¦thereÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦otherÂ¦ Â¦contr ai nd icationsÂ¦ Â¦forÂ¦ Â¦specificÂ¦ Â¦vaccinesÂ¦ ,â– Â¦whichÂ¦ Â¦needÂ¦ Â¦dis cu ssingÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦healthcareÂ¦ Â¦providerÂ¦ .
ğ‹‡Â¦vaccinesÂ¦ Â¦areÂ¦ Â¦usedÂ¦ Â¦worldwideÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦highlyÂ¦ Â¦effectiveÂ¦ Â¦wayÂ¦ Â¦toÂ¦ Â¦protectÂ¦ Â¦peopleÂ¦ Â¦fromÂ¦ Â¦contr actingÂ¦ Â¦infectiousÂ¦ Â¦diseasesÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦firstÂ¦ Â¦vaccineÂ¦ Â¦wasÂ¦ Â¦developedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦18 thÂ¦ Â¦ cent uryÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡ Â¦unitedÂ¦ ğ‹‡ Â¦kingdomÂ¦ .
ğ‹‡Â¦n ow ad aysÂ¦ ,â– Â¦thereÂ¦ Â¦areÂ¦ Â¦vaccinesÂ¦ Â¦forÂ¦ Â¦manyÂ¦ Â¦diseasesÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦videoÂ¦ Â¦isÂ¦ Â¦availableÂ¦ Â¦inÂ¦ Â¦24Â¦  Â¦l an gu agesÂ¦ .
ğ‹‡ Â¦safetyÂ¦ ,â– Â¦qualityÂ¦ Â¦andÂ¦ Â¦standardsÂ¦
ğ‹‡Â¦beforeÂ¦ Â¦anyÂ¦ Â¦newÂ¦ Â¦vaccineÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦usedÂ¦ ,â– Â¦itÂ¦ Â¦hasÂ¦ Â¦toÂ¦ Â¦underg oÂ¦ Â¦r ig or ousÂ¦ Â¦testingÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦evalu ationÂ¦ Â¦needsÂ¦ Â¦toÂ¦ Â¦showÂ¦ Â¦thatÂ¦ Â¦aÂ¦ Â¦vaccineÂ¦ â€™ Â¦sÂ¦ Â¦benef itsÂ¦ Â¦inÂ¦ Â¦protectingÂ¦ Â¦peopleÂ¦ Â¦againstÂ¦ Â¦diseasesÂ¦ Â¦areÂ¦ Â¦farÂ¦ Â¦greaterÂ¦ Â¦thanÂ¦ Â¦anyÂ¦ Â¦potentialÂ¦ Â¦riskÂ¦ .
ğ‹‡Â¦onlyÂ¦ Â¦thenÂ¦ ,â– Â¦afterÂ¦ Â¦approvalÂ¦ ,â– Â¦canÂ¦ Â¦aÂ¦ Â¦vaccineÂ¦ Â¦beÂ¦ Â¦manufact uredÂ¦ ,â– Â¦mar ke tedÂ¦ Â¦andÂ¦ Â¦usedÂ¦ Â¦toÂ¦ Â¦protectÂ¦ Â¦peopleÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦withÂ¦ Â¦anyÂ¦ Â¦medicineÂ¦ ,â– Â¦someÂ¦ Â¦peopleÂ¦ Â¦mayÂ¦ Â¦experienceÂ¦ Â¦sideÂ¦ Â¦effectsÂ¦ Â¦fromÂ¦ Â¦aÂ¦ Â¦vaccineÂ¦ ,â– Â¦butÂ¦ Â¦theseÂ¦ Â¦areÂ¦ Â¦usuallyÂ¦ Â¦mildÂ¦ Â¦andÂ¦ Â¦shortÂ¦ - Â¦li vedÂ¦ .
ğ‹‡ Â¦benef itsÂ¦ Â¦ofÂ¦ Â¦v accin atingÂ¦
ğ‹‡Â¦vaccinesÂ¦ Â¦preventÂ¦ Â¦diseasesÂ¦ Â¦thatÂ¦ Â¦couldÂ¦ Â¦otherwiseÂ¦ Â¦causeÂ¦ Â¦seriousÂ¦ Â¦healthÂ¦ Â¦problemsÂ¦ ,â– Â¦perm an entÂ¦ Â¦disabilityÂ¦ Â¦orÂ¦ Â¦evenÂ¦ Â¦deathÂ¦ .
ğ‹‡Â¦forÂ¦ Â¦exampleÂ¦ ,â– Â¦duringÂ¦ Â¦20 18Â¦ Â¦aboutÂ¦ Â¦8 6Â¦ %â– Â¦ofÂ¦ Â¦infantsÂ¦ Â¦worldwideÂ¦ Â¦receivedÂ¦ Â¦threeÂ¦ Â¦dosesÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦thatÂ¦ Â¦prot ectsÂ¦ Â¦themÂ¦ Â¦againstÂ¦ Â¦di ph th eriaÂ¦ ,â– Â¦t et an usÂ¦ Â¦andÂ¦ Â¦p ert us sisÂ¦ â–(  ),â– Â¦andÂ¦ Â¦8 5Â¦ %â– Â¦ofÂ¦ Â¦infantsÂ¦ Â¦aroundÂ¦ Â¦theÂ¦ Â¦worldÂ¦ Â¦receivedÂ¦ Â¦threeÂ¦ Â¦dosesÂ¦ Â¦ofÂ¦ Â¦po lioÂ¦ Â¦vaccineÂ¦ â–( Â¦1Â¦ ).
ğ‹‡ Â¦unli keÂ¦ Â¦aÂ¦ Â¦treatmentÂ¦ Â¦givenÂ¦ Â¦toÂ¦ Â¦c ureÂ¦ Â¦anÂ¦ Â¦illnessÂ¦ ,â– Â¦vaccinesÂ¦ Â¦areÂ¦ Â¦usuallyÂ¦ Â¦givenÂ¦ Â¦toÂ¦ Â¦healthyÂ¦ Â¦peopleÂ¦ Â¦toÂ¦ Â¦preventÂ¦ Â¦themÂ¦ Â¦fromÂ¦ Â¦gettingÂ¦ Â¦illÂ¦ .
ğ‹‡Â¦manyÂ¦ Â¦infectiousÂ¦ Â¦diseasesÂ¦ Â¦areÂ¦ Â¦veryÂ¦ Â¦r areÂ¦ Â¦todayÂ¦ Â¦t han ksÂ¦ Â¦toÂ¦ Â¦vaccinationÂ¦ ,â– Â¦soÂ¦ Â¦theÂ¦ Â¦negativeÂ¦ Â¦conse qu encesÂ¦ Â¦ofÂ¦ Â¦theseÂ¦ Â¦diseasesÂ¦ Â¦areÂ¦ Â¦sometimesÂ¦ Â¦for g o tt enÂ¦ .
ğ‹‡ Â¦exampleÂ¦ :â– Â¦measlesÂ¦
ğ‹‡ Â¦measlesÂ¦ Â¦hadÂ¦ Â¦almostÂ¦ Â¦beenÂ¦ Â¦eli min atedÂ¦ Â¦inÂ¦ Â¦manyÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦countriesÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦sinceÂ¦ ğ‹‡ Â¦octoberÂ¦ Â¦201 6Â¦ Â¦aÂ¦ Â¦res ur g enceÂ¦ Â¦ofÂ¦ Â¦measlesÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦observedÂ¦ Â¦inÂ¦ Â¦theÂ¦  /  ,â– Â¦withÂ¦ Â¦outbreaksÂ¦ Â¦inÂ¦ Â¦severalÂ¦ Â¦countriesÂ¦ â–( Â¦2Â¦ ),â– Â¦dueÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦dec lineÂ¦ Â¦inÂ¦ Â¦vaccinationÂ¦ Â¦ratesÂ¦ .
ğ‹‡ Â¦measlesÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦seriousÂ¦ Â¦orÂ¦ Â¦evenÂ¦ Â¦lifeÂ¦ - Â¦threat eningÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦onlyÂ¦ Â¦protectionÂ¦ Â¦againstÂ¦ Â¦measlesÂ¦ Â¦isÂ¦ Â¦vaccinationÂ¦ .
ğ‹‡ Â¦exampleÂ¦ :â– Â¦p ert us sisÂ¦
ğ‹‡Â¦p ert us sisÂ¦ â–( Â¦who o pingÂ¦ Â¦coughÂ¦ )â– Â¦isÂ¦ Â¦aÂ¦ Â¦diseaseÂ¦ Â¦affectingÂ¦ Â¦theÂ¦ Â¦air waysÂ¦ .
ğ‹‡ Â¦complicationsÂ¦ Â¦canÂ¦ Â¦includeÂ¦ Â¦pneumoniaÂ¦ ,â– Â¦en cep ha lo pa thyÂ¦ â–( Â¦aÂ¦ Â¦diseaseÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦bra inÂ¦ ),â– Â¦se iz uresÂ¦ Â¦andÂ¦ Â¦evenÂ¦ Â¦deathÂ¦ .
ğ‹‡ Â¦vaccinationÂ¦ Â¦againstÂ¦ Â¦p ert us sisÂ¦ Â¦isÂ¦ Â¦partÂ¦ Â¦ofÂ¦ Â¦nationalÂ¦ Â¦immun isationÂ¦ Â¦programmesÂ¦ Â¦inÂ¦ Â¦theÂ¦  .
ğ‹‡ Â¦approvalÂ¦ Â¦ofÂ¦ Â¦vaccinesÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦unionÂ¦
ğ‹‡Â¦beforeÂ¦ Â¦aÂ¦ Â¦vaccineÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦approvedÂ¦ Â¦inÂ¦ Â¦theÂ¦  ,â– Â¦itÂ¦ Â¦hasÂ¦ Â¦toÂ¦ Â¦underg oÂ¦ Â¦r ig or ousÂ¦ Â¦testingÂ¦ Â¦byÂ¦ Â¦itsÂ¦ Â¦de velop erÂ¦ Â¦andÂ¦ Â¦thenÂ¦ Â¦scientificÂ¦ Â¦evalu ationÂ¦ Â¦byÂ¦ Â¦reg ulatoryÂ¦ Â¦authoritiesÂ¦ .
ğ‹‡ Â¦testingÂ¦ Â¦includesÂ¦ Â¦chec kingÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ â€™ Â¦sÂ¦ Â¦qualityÂ¦ :
Â¦itsÂ¦ Â¦pur ityÂ¦ ;
Â¦itsÂ¦ Â¦ingredi entsÂ¦ ,â– Â¦includingÂ¦ Â¦itsÂ¦ Â¦in activeÂ¦ Â¦ingredi entsÂ¦ Â¦orÂ¦ â– â€˜ Â¦exc ip i entsÂ¦ â€™ ;
Â¦howÂ¦ Â¦itÂ¦ Â¦isÂ¦ Â¦manufact uredÂ¦ .
ğ‹‡Â¦thenÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦de velop erÂ¦ Â¦testsÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ â€™ Â¦sÂ¦ Â¦effectsÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦isÂ¦ Â¦followedÂ¦ Â¦byÂ¦ Â¦aÂ¦ Â¦clinicalÂ¦ Â¦testingÂ¦ Â¦programmeÂ¦ Â¦inÂ¦ Â¦humansÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦canÂ¦ Â¦takeÂ¦ Â¦aroundÂ¦ Â¦tenÂ¦ Â¦yearsÂ¦ Â¦fromÂ¦ Â¦initialÂ¦ Â¦con cep tÂ¦ Â¦toÂ¦ Â¦author isationÂ¦ .
Â¦20Â¦ â–-â– Â¦100Â¦ Â¦healthyÂ¦ Â¦volu n te ersÂ¦
ğ‹‡Â¦whatÂ¦ Â¦isÂ¦ Â¦chec kedÂ¦ :â–
ğ‹‡ Â¦doesÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦see mÂ¦ Â¦toÂ¦ Â¦workÂ¦ ?
ğ‹‡Â¦areÂ¦ Â¦thereÂ¦ Â¦seriousÂ¦ Â¦sideÂ¦ Â¦effectsÂ¦ ?
ğ‹‡ Â¦isÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦safeÂ¦ ?
ğ‹‡Â¦atÂ¦ Â¦theÂ¦ Â¦endÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦testingÂ¦ Â¦programmeÂ¦ ,â– Â¦theÂ¦ Â¦vaccineÂ¦ Â¦de velop erÂ¦ Â¦sub m itsÂ¦ Â¦theÂ¦ Â¦resultsÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦medicinesÂ¦ Â¦reg ulatoryÂ¦ Â¦authoritiesÂ¦ Â¦inÂ¦ ğ‹‡ Â¦europeÂ¦ Â¦asÂ¦ Â¦partÂ¦ Â¦ofÂ¦ Â¦aÂ¦ â– â€˜ Â¦mar ke tingÂ¦ Â¦author isationÂ¦ â€™ â– Â¦applicationÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦reg ul atorsÂ¦ Â¦canÂ¦ Â¦onlyÂ¦ Â¦appro veÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦ifÂ¦ Â¦itsÂ¦ Â¦scientificÂ¦ Â¦evalu ationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦testsÂ¦ Â¦resultsÂ¦ Â¦showÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ â€™ Â¦sÂ¦ Â¦benef itsÂ¦ Â¦areÂ¦ Â¦greaterÂ¦ Â¦thanÂ¦ Â¦itsÂ¦ Â¦ris ksÂ¦ .
ğ‹‡ Â¦medicinesÂ¦ Â¦reg ulatoryÂ¦ Â¦authoritiesÂ¦ Â¦canÂ¦ Â¦car ryÂ¦ Â¦outÂ¦ Â¦in sp ectionsÂ¦ Â¦toÂ¦ Â¦makeÂ¦ Â¦sureÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦informationÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦de velop erÂ¦ Â¦providesÂ¦ Â¦isÂ¦ Â¦tr ust wor thyÂ¦ .
ğ‹‡ Â¦monitoringÂ¦ Â¦vaccineÂ¦ Â¦safetyÂ¦ Â¦andÂ¦ Â¦reportingÂ¦ Â¦sideÂ¦ Â¦effectsÂ¦
ğ‹‡ Â¦onceÂ¦ Â¦aÂ¦ Â¦vaccineÂ¦ Â¦isÂ¦ Â¦approvedÂ¦ Â¦forÂ¦ Â¦useÂ¦ ,â–  /  Â¦nationalÂ¦ Â¦authoritiesÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦medicinesÂ¦ ğ‹‡ Â¦agencyÂ¦
(  ),â– Â¦contin uallyÂ¦ Â¦monitorÂ¦ Â¦sideÂ¦ Â¦effectsÂ¦ Â¦inÂ¦ Â¦peopleÂ¦ Â¦whoÂ¦ Â¦haveÂ¦ Â¦receivedÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦ ens uresÂ¦ Â¦thatÂ¦ Â¦anyÂ¦ Â¦possibleÂ¦ Â¦ris ksÂ¦ Â¦areÂ¦ Â¦detectedÂ¦ Â¦andÂ¦ Â¦manag edÂ¦ Â¦asÂ¦ Â¦soonÂ¦ Â¦asÂ¦ Â¦possibleÂ¦ .
 Â¦chec ksÂ¦ Â¦newÂ¦ Â¦informationÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦safetyÂ¦ Â¦ofÂ¦ Â¦allÂ¦ Â¦vaccinesÂ¦ Â¦availableÂ¦ Â¦inÂ¦ ğ‹‡ Â¦europeÂ¦ .â– ğ‹‡Â¦itÂ¦ Â¦anal y sesÂ¦ Â¦manyÂ¦ Â¦sourcesÂ¦ Â¦ofÂ¦ Â¦dataÂ¦ ,â– Â¦includingÂ¦ :
Â¦reportsÂ¦ Â¦fromÂ¦ Â¦patientsÂ¦ ,â– Â¦parentsÂ¦ Â¦andÂ¦ Â¦healthcareÂ¦ Â¦prof es sion alsÂ¦ ;
Â¦clinicalÂ¦ Â¦studiesÂ¦ ;
Â¦theÂ¦ Â¦medicalÂ¦ Â¦li ter at ureÂ¦ ;
Â¦informationÂ¦ Â¦sharedÂ¦ Â¦byÂ¦ Â¦otherÂ¦ Â¦reg ul atorsÂ¦ .
 Â¦carefullyÂ¦ Â¦ass es sesÂ¦ Â¦suspectedÂ¦ Â¦sideÂ¦ Â¦effectsÂ¦ Â¦toÂ¦ Â¦determineÂ¦ Â¦ifÂ¦ Â¦thereÂ¦ Â¦isÂ¦ Â¦aÂ¦ Â¦ca us alÂ¦ Â¦linkÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦orÂ¦ Â¦notÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦videoÂ¦ Â¦isÂ¦ Â¦availableÂ¦ Â¦inÂ¦ Â¦24Â¦  Â¦l an gu agesÂ¦ .
ğ‹‡Â¦whenÂ¦ Â¦neededÂ¦ ,â–  Â¦andÂ¦ Â¦theÂ¦ Â¦otherÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦reg ul atorsÂ¦ Â¦takeÂ¦ Â¦actionÂ¦ .
ğ‹‡Â¦patientsÂ¦ ,â– Â¦healthcareÂ¦ Â¦prof es sion alsÂ¦ Â¦andÂ¦ Â¦ph ar m ac eut icalÂ¦ Â¦companiesÂ¦ Â¦shouldÂ¦ Â¦reportÂ¦ Â¦allÂ¦ Â¦suspectedÂ¦ Â¦sideÂ¦ Â¦effectsÂ¦ Â¦toÂ¦ Â¦theirÂ¦ Â¦nationalÂ¦ Â¦medicinesÂ¦ Â¦reg ulatoryÂ¦ Â¦authorityÂ¦ .
ğ‹‡ Â¦informationÂ¦ Â¦onÂ¦ Â¦theseÂ¦ Â¦reportedÂ¦ Â¦suspectedÂ¦ Â¦sideÂ¦ Â¦effectsÂ¦ Â¦isÂ¦ Â¦publ ic lyÂ¦ Â¦availableÂ¦ Â¦onÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦d at ab aseÂ¦ Â¦ofÂ¦ Â¦suspectedÂ¦ Â¦adverseÂ¦ Â¦drugÂ¦ Â¦reactionÂ¦ Â¦reportsÂ¦ .â–
ğ‹‡Â¦theÂ¦ Â¦processÂ¦ Â¦ofÂ¦ Â¦monitoringÂ¦ Â¦theÂ¦ Â¦safetyÂ¦ Â¦andÂ¦ Â¦manag ingÂ¦ Â¦theÂ¦ Â¦ris ksÂ¦ Â¦ofÂ¦ Â¦medicinesÂ¦ Â¦isÂ¦ Â¦calledÂ¦ â– â€˜ Â¦ph ar m ac ov ig il anceÂ¦ â€™ .
ğ‹‡ Â¦vaccineÂ¦ Â¦effectivenessÂ¦
ğ‹‡Â¦aÂ¦ Â¦vaccineÂ¦ ' Â¦sÂ¦ Â¦abilityÂ¦ Â¦toÂ¦ Â¦preventÂ¦ Â¦aÂ¦ Â¦specificÂ¦ Â¦diseaseÂ¦ Â¦det erm inesÂ¦ Â¦itsÂ¦ Â¦effectivenessÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦withÂ¦ Â¦anyÂ¦ Â¦medicineÂ¦ ,â– Â¦noÂ¦ Â¦vaccineÂ¦ Â¦isÂ¦ Â¦100Â¦ %â– Â¦effectiveÂ¦ Â¦inÂ¦ Â¦everyÂ¦ Â¦personÂ¦ Â¦vaccinatedÂ¦ .
ğ‹‡Â¦theseÂ¦ Â¦includeÂ¦ :
